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This thesis details the novel use of the Medipix All Resolution System (MARS) Spectral CT
scanner for quantitative imaging of vulnerable atherosclerotic plaque. The motivation behind
this research was to see how well the MARS scanner could identify and quantify common com-
ponents that are present in atheromas. Characteristic features of vulnerable plaque include a
large necrotic lipid core, thin fibrous cap, increased inflammation, and intraplaque haemorrhage.
The ability to identify lipid was investigated by joining high-Z contrast agents to low-density
lipoproteins, enhancing the signal of a lipid component using spectral CT. Contrast agents were
also implemented using U937 cells and macrophages, following the progressive lifecycle of the
disease.
The elements iron and calcium were investigated in relation to their similar spectral pro-
files. With microcalcifications attributed to plaque instability, and iron a key component in
blood, and hence intraplaque haemorrhage, the ability to distinguish these materials is crucial
for identifying vulnerable plaque features in a clinical setting. Phantom studies involving iron-
and calcium- like materials were performed to optimise the phantom and scanning protocol.
Misidentifications between specific material concentrations in the material decomposition un-
derwent further analysis with new methods that used the energy information from the scan.
This revealed that misidentified materials could be separated and distinguished with the spec-
tral information, demonstrating the advantage of spectral CT for atherosclerosis imaging over
other imaging modalities. With the coexistence of iron and calcium deposits in atherosclerotic
plaque, a point of discussion surrounds the issue of whether the MARS scanner can identify
these two materials simultaneously, given there is a large enough signal. This was investigated
through a mixed phantom of iron- and calcium- like solutions, to determine the point at which
the iron signal predominates, and predominates over every other signal. In time, improvements
to the scanner and the material decomposition software will lead to reduced misidentification
of materials, and stronger distinction between iron and calcium .
The experiments performed throughout this thesis contribute to the field of atherosclerosis
and the capabilities of the MARS Spectral CT scanner to identify and quantify elemental
features of vulnerable plaque. With the MARS team fast approaching the goal of bringing multi-
energy CT to human scanning, this research establishes firm ground for continued atheroma
studies to help bring spectral CT to clinical imaging of atherosclerosis.
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This thesis details work contributing to the quantification of vulnerable atherosclerotic plaque
features using MARS spectral CT. Spectral CT technology is at the forefront of the medical
imaging field, with the ultimate goal of the MARS team being the establishment of a commer-
cial spectral CT scanner for clinical use. The goal of this thesis is to set out a framework for
atherosclerosis imaging using the MARS scanner. This was achieved by investigating the main
components that feature in vulnerable atherosclerotic plaque. Each component of vulnerable
plaque is organised into a designated chapter, including experiments involving lipid characterisa-
tion, and the distinction between calcifications and iron deposits. It demonstrates that spectral
CT can image and quantify biological progresses taking place at a molecular level, through the
use of high-Z contrast agents such as iodine and gold nanoparticles.
The visualisation of low contrast materials such as lipid is difficult in conventional CT, where
the separation between materials is not easily recognisable in greyscale images. This thesis ac-
cesses the high-Z contrast agents iodine and gold joined to low-density lipoproteins (LDL’s), to
image and quantify the amount of nanoparticles joined to LDL’s through the material decom-
position. The motivation for this was based on the stages of plaque progression, where LDL’s
are initially recruited to the arterial wall due to a dysfunction of the endothelium [1]. Further
contrast agent studies lead to the application of a human macrophage cell line known as U937
cells. The amount of contrast taken up by the cells more closely resembles the mechanism of
uptake in human cells in atherosclerosis progression.
This thesis also delves into the matter of distinguishing iron and calcium. Iron is the ma-
terial component of vulnerable plaques that represents the feature of intraplaque haemorrhage.
Calcium relates to both the prevention and progression of plaque vulnerability. Large calcified
regions provide plaques with stability, while microcalcifications indicate destabilisation of the
atheroma. The major challenge in separating these materials relates to their similar spectral
profiles. Neither material has a k-edge within the diagnostic energy range (20 - 120 keV),
and hence exhibit similar Compton and photoelectric contributions to their attenuation coef-
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2 CHAPTER 1. INTRODUCTION
ficients over the energy range investigated [2]. As a result, iron and calcium cannot be easily
distinguished using material decomposition. Phantom studies investigated the ability to sep-
arate these materials on the energy information collected from each scan, with new methods
comparing the material decomposition result with the material separation at each energy range.
Figure 1.1: A logarithmic plot of x-ray attenuation for different human tissues as a function of
x-ray energy. It illustrates that the attenuation difference between tissues is maximum at the
lower energies and decreases with increasing energy. Notice bone (calcium) and blood (iron)
have no k-edge jump within this energy range, and hence cannot be easily distinguished within
the diagnostic energy range.
Throughout the timeframe of this thesis, multiple excised plaque specimens and atheroscle-
rosis mouse models were scanned and visualised using the MARS Spectral scanner. The results
of the optimised images produced are showcased in this thesis, demonstrating the abilities of the
MARS scanner to obtain multi-energy datasets from a single acquisition using a standard x-ray
tube operated at a single accelerating voltage [3]. Compared to current clinical imaging tech-
niques, multi-energy CT is a superior imaging modality for atherosclerosis research, providing
images with improved contrast, spatial resolution, and a reduction in imaging artefacts. With
the MARS technology in the process of being adapted to a commercial, human-sized scanner,
the clinical applications of spectral CT and the ability to improve patient treatments will be
fully realised.
My contribution in the MARS project is mentioned in the previous section of Academic
Contribution. This chapter introduces the motivation of the thesis and the goals of the Medipix
All Resolution System (MARS) research group. The clinical relevance of this work is given in
section 1.1. An overview of spectral CT imaging and the MARS scanner is provided in section
1.2, with a thesis outline provided in section 1.3.
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1.1 Clinical Significance
The ability of the MARS Spectral scanner to simultaneously acquire high resolution images
with spectral information creates the potential for major clinical advances. The utilisation
of high-atomic number materials as contrast agents enables the MARS scanner to show the
presence of these nanoparticles bound to biological samples in regions activated by vulnerable
plaque rupture. This allows for identification and quantification of inflammatory components of
vulnerable plaque, a feat not yet achieved with other imaging modalities. Recognition of plaque
vulnerability is paramount to successful prevention of thrombotic events in patients, such as a
stroke or myocardial infarction.
Atherosclerosis is a progressive but silent killer, with usual measures put in place too late
before consequences present themselves. In New Zealand and across the world, cardiovascular
disease is the leading cause of death. 33% of New Zealand deaths are attributed to the disease
annually, with 172,000 New Zealanders living with heart disease [4]. Current imaging methods
for patients presenting with a transient ischaemic attack measure plaque size as a basic tool for
determining whether the patient requires endarterectomy or continued medical assessment [5].
Spectral molecular imaging has the potential to identify active disease activity, hence providing
personalised preventative treatment for stroke patients. Patients susceptible to coronary artery
disease could have unstable lesions identified and stented, thus directing treatment to prevent
a myocardial infarction occurring [5]. As the MARS group prepares to transition to human
scanning in coming years, this technique could facilitate in vivo visualisation and assessment of
atherosclerotic plaques in patients ahead of treatment, effectively streamlining the selection of
candidates for surgery, and the ability to monitor atherosclerosis disease.
1.2 Background
Spectral computed tomography (CT) is shifting the traditional view of medical imaging, revo-
lutionising the way medical professionals and researchers view and interpret CT images. This
technology has the ability to image in colour by using energy-resolving detectors to acquire
spectral data [3], succeeding greyscale CT from which it is based. Spectral molecular imaging is
opening avenues for interpretation of images and diagnosis of diseases which were not achievable
or fully exploited with conventional CT.
The imaging modality of CT uses a polychromatic x-ray source to produce a 3D image of an
object being scanned. The image is attained due to the photon interactions within the object.
As x-rays of varying energies are emitted from the source and travel through the object, the
photons are attenuated to different degrees depending on the material’s atomic composition, and
the energy of the respective photons. Conventional CT encodes the attenuations from different
materials in greyscale (Hounsfield Units) by using energy integration detectors across the entire
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broad x-ray spectrum. The issue surrounding this tactic is that different materials appearing
in the CT image may have similar, if not the same, Hounsfield Units at specific concentrations.
Therefore, these materials cannot be distinguished from each other, and the energy dependent
characteristics of the materials attenuation are not observed.
Spectral CT acquires attenuation information by measuring x-ray absorption at multiple
energy ranges. This is achieved by dividing a single energy spectrum into separate energy bins
to extract energy information from the x-ray beam. By sampling several sections of the energy
spectrum simultaneously, this provides a range of energy-dependent Hounsfield units across the
spectrum [5]. For the energy range relevant to diagnostic imaging, x-ray interactions are pre-
dominantly a combination of the photoelectric effect and Compton scatter. The photoelectric
effect is the release of an electron from the innermost shell of an atom (the K shell) by a photon
with an energy greater than the binding energy of the K shell [6]. This is depicted by the spike
in attenuation in a materials’ spectral profile, representing the total energy of any incoming
photon being absorbed. Compton scattering is the collision of photons with valence electrons
of the outermost shell of an atom. In this collision, the energy of the incoming photon is not
fully absorbed, leading to photon scatter.
Materials have specific spectral profiles based on their distinctive energy-dependent atten-
uation characteristics. For each material, this relates to differences in the photoelectric effect
at low photon energies and the stability of Compton scattering at higher photon energies [7].
The Hounsfield units of high-atomic number (high-Z) materials decrease with energy as the
effect of photoelectric absorption diminishes, whereas the Hounsfield units for low-Z materials
increases with energy. This gives each material a unique Hounsfield unit shaped spectral profile,
including k-edge peaks relating to the composition of the material. Both photoelectric effect
and Compton scattering are energy dependent, and thus spectral decomposition is feasible with
CT data acquired over at least two energy bins [3].
The MARS Spectral scanner is a multi-energy system that uses an energy-discriminating
Medipix detector, capable of measuring the attenuation of x-rays in various energy ranges. The
MARS scanner uncouples the x-ray spectrum into separate energy bins to extract energy in-
formation from the x-ray beam. The photon-processing abilities of the Medipix3RX detector
implemented in the scanner enables high atomic number materials to be identified through
their respective K-edges, which are observed by the sudden increase in attenuation due to pho-
toelectric absorption of the photons [8]. In this arrangement, when a photon collides with the
Medipix3RX detector, a current pulse is generated proportional to the energy of the detected
x-ray photon [6]. If the energy of the detected photon is above the energy threshold on the
detector chip then it is counted. Subsequently the detected photon is allocated to a respective
energy bin, providing energy-selective images. By setting limits on the energy bins for a ma-
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terial of interest, a specific material can be detected more easily. As such, sampling selected
photon energy bins simultaneously allows characterisation of tissues on the basis of the k-edge
behaviour of the materials making up the tissue [6].
Current imaging modalities have been implemented to study atherosclerosis, but are limited
in assessing plaque vulnerability. CT is an excellent calcium quantifier, but cannot distinguish or
quantify components of vulnerable plaque if they occupy the same voxel [7]. Magnetic resonance
imaging (MRI) is able to distinguish components of vulnerable plaque, but cannot accurately
quantify necrotic lipid cores [9]. Dual-energy CT (DECT) acquires images at two x-ray energy
levels, however the modality is limited by the inconsistency between low and high x-ray energy
data, resulting in beam-hardening artefacts [7]. The combination of high spatial resolution
with improved intrinsic soft tissue contrast and specificity gives spectral CT the potential to
characterise features of vulnerable plaque.
(a) Picture of MARS spectral scanner. (b) Picture of the MARS gantry.
Figure 1.2: The MARS spectral scanner.
The MARS group is a multidisciplinary team of physicists, medical physicists, clinical radi-
ologists, mathematicians, engineers, computer scientists, and biologists. Based at the University
of Canterbury, the MARS group works alongside the University of Otago and their associated
partners. A significant partnership is with CERN in Geneva, where the Medipix detectors are
developed. At present, MARS spectral CT has been implemented at the pre-clinical stage, in
a small animal scanner suitable for scanning phantoms, small animal models and excised tis-
sue samples. The future focus of the MARS group is translating this technology to develop a
commercial, human scale MARS scanner suitable for clinical use.
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1.3 Thesis Outline
This thesis reports on the contributions made towards quantifying and identifying features of
vulnerable atherosclerotic plaque. The present chapter provides a background to x-ray physics
and spectral CT technology. The experimental work covering the lipid component of atheroscle-
rosis is covered in chapter 2. Chapter 3 details experiments performed to distinguish iron from
calcium. A new analysis method PCA is developed in chapter 4, using results from experiments
in chapter 3. Chapter 5 showcases the ability of the MARS spectral scanner with plaque spec-
imens and apoE mice material decomposition results. A conclusion to the thesis is given in
chapter 6. Detailed summaries for chapters 1-5 are provided below.
Chapter 1 provides an introduction to the thesis, including the motivation of the project,
the goal of the MARS team, and the clinical significance in the field of atherosclerosis. An
outline of the contents of the thesis is also given.
Chapter 2 introduces lipid, an important feature of vulnerable atherosclerotic plaques. The
use of nanoparticle contrast agents for plaque imaging is introduced. Experiments joining high-Z
contrast agents are explored through the various stages of plaque progression. Material decom-
position performed on the phantom studies reveals the nanoparticles’ ability to visualise and
quantify lipid components in plaque.
Chapter 3 discusses the components of iron and calcium, and their importance in determin-
ing plaque stability and indicating plaque vulnerability. The coexistence of these materials is
investigated in an attempt to separate their spectral signals. The experiments aim to optimise
the phantom and scanning protocol used throughout this chapter.
Chapter 4 provides an overview to Principal Component Analysis, an analysis technique
applied to the spectral datasets in Chapter 3 for evaluating the separation of materials. Im-
provements to the method are briefly discussed.
Chapter 5 showcases the potential of the MARS spectral scanner through numerous plaque
and apoE mice scans. Material decomposition images are shown and interpreted by optimising
the MARS MD visualisation settings. Issues with the material identification in the images are
raised, with future experiments to improve material decomposition discussed.




The aim of this chapter is to investigate lipid in atherosclerosis through experiments reflecting
the composition of lipid in atheromas. The significance of this chapter enables visualisation
and quantification of lipid components using spectral CT, facilitating the long term goal of vul-
nerable plaque recognition in patients and directing suitable treatment. This chapter provides
a background to the lipid component of atherosclerosis and the processes involved in vulnera-
ble plaque formation. The progression of atherogenesis is investigated through a sequence of
experiments that follow the lipid lifecycle until its furthermost intention, the occurrence of a
thrombotic event. This involves the use of high-Z material based exogenous contrast agents
such as gold and iodine, which are essential for categorizing soft tissue biomarkers of vulnerable
plaque within the human imaging energy range (20 – 120 keV).
Section 2.2 gives an overview of lipids in atherosclerosis and their role in a plaques progression
to vulnerability. The use of nanoparticle contrast agents for plaque imaging is also introduced.
The methods, results, and analysis of each lipid experiment are given in individual sections.
Section 2.3 talks about the iodinated LDL experiment, while section 2.4 describes the experiment
joining gold and iodine to native-LDL. Section 2.5 investigates the use of contrast agents joined
to U937 cells for translation to a biological specimen. Section 2.6 gives insight to the experiment
implementing gold nanoparticles to macrophages, with the chapter summary in section 2.7.
2.2 Lipid in atherosclerosis
Unstable or vulnerable plaque is an adverse component of atherosclerosis, with the risk of suffer-
ing a thrombotic event more dependent on the biochemical and cell composition of the plaque,
rather than the lesions stenotic severity [11]. Following the systemic inflammatory process
of atherosclerosis, vulnerable plaques are characterized having features including: (a) a large
necrotic lipid core; (b) thin fibrous cap; (c) increased inflammation; (d) reduced collagen and
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amount of vascular smooth muscle cells (VSMCs); (e) increased vasa-vasorum neovasculariza-
tion; and (f) intraplaque haemorrhage.
Low-density lipoproteins
Lipids such as cholesterol and triglycerides are insoluble in water, hence they must be trans-
ported in association with proteins. Lipoproteins are particles that comprise a central core
containing cholesterol esters and triglycerides surrounded by free cholesterol, phospholipids,
and apolipoproteins. The governing role of lipoprotein particles is to transfer these lipids
throughout the body in the extracellular fluid, facilitating the availability of fats to cells via
receptor-medicated endocytosis. Plasma lipoproteins can be categorized into seven classes based
on their size, lipid composition, and apolipoproteins: chylomicrons, chylomicron remnants, very
low-density lipoproteins (VLDL), intermediate-density lipoproteins (IDL), low-density lipopro-
teins (LDL), high-density lipoproteins (HDL), and lipoprotein(a) (Lp(a)).
Figure 2.1: Image detailing the structure of a LDL particle. Accessed from [12].
The two main groups of lipoproteins are HDL and LDL. HDL particles are known as the
‘good’ cholesterol in the body, as they collect free cholesterol from peripheral tissues and trans-
port these out of arterial walls [13], and reduce macrophage accumulation, potentially fore-
stalling any onset of atherosclerosis. LDL particles are classified as the ‘bad’ cholesterol, as
when they invade the endothelium, the oxidized forms they become are more easily retained by
proteoglycans, and hence promote atherosclerosis development.
Apolipoproteins are proteins that bind lipids like cholesterol and triglycerides to form
lipoproteins, and play a crucial role in lipoprotein metabolism. Their major functions include a)
serving a structural role for maintaining the lipoprotein particle, b) acting as ligands for inter-
action with lipoprotein receptors in tissues (apoB100 and apoE for LDL-receptors, and apoA-I
for HDL receptors), c) guiding the formation of lipoproteins, and d) serving as activators or
inhibitors of enzymes involved in lipoprotein metabolism [12].
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The role of macrophages
Macrophages are a type of white blood cell responsible for engulfing cellular debris, apoptotic
cells, and other foreign bodies through phagocytosis. In atherosclerosis, macrophages contribute
to size-dependent variations in plaque morphology, particularly the formation of the necrotic
core and fibrous cap thinning [14]. Macrophages accumulated in plaques tend to have diminished
ability to migrate, making it inactive in resolving inflammation and contributing to plaque
progression. Through their death via necrosis or apoptosis, the immobile macrophages release
their lipid contents to form the pro-thrombotic necrotic core [15]. The thin fibrous cap is
the connective tissue layer that covers the necrotic core, and is composed of VSMCs and the
extracellular matrix (ECM) they synthesise (predominantly collagen and proteoglycans). The
fibrous cap also contains macrophage foam cells. The balance between the constituents within
the ECM plays a vital role in maintaining the integrity of the fibrous cap, and its vulnerability
to rupture [11].
Plaque progression
The development of atherosclerosis is initiated by the dysfunction of the endothelium, due to
stimuli such as smoking, hypertension, or dyslipidemia. The endothelium is a semipermeable
membrane that forms the inner layer of blood vessels, and controls the transit of materials in
and out of the bloodstream [13]. A compensatory response to a disruption in the endothelium
leads to recruitment of low-density lipoproteins (LDL’s) by increasing the endothelium’s perme-
ability, allowing adhesion and migration into the arterial wall. A focal area for this migration is
at branch points of the arterial tree, which encounter laminar flow disturbance [16]. The LDL’s
are retained in the intima through the binding of apolipoproteins B100 to negatively charged
proteoglycans of the ECM[17][18].
As the LDL particles accumulate, they undergo chemical modifications inside the intima.
Oxidation of the LDL particles renders them pro-atherogenic. This results from the chemical
reactions of reactive oxygen species (ROS) and pro-oxidant enzymes produced by the endothe-
lium, smooth muscle cells (SMCs), or macrophages penetrating the intima to induce oxidative
stress [19]. As the LDL particles are progressively oxidized, they are capable of acting as a
chemoattractant, exerting their pro-atherogenic effects to recruit leukocytes (monocytes and
lymphocytes), which migrate into the intima. This generally occurs in preferential areas where
the subendothelial layer is abundant with oxidized LDL particles [11].
When monocytes enter the intima, they differentiate into phagocytic macrophages and ex-
press scavenger receptors. LDL particles that are completely oxidized, as characterized by an
increased apolipoprotein B100 negative charge, are recognized by the scavenger receptors and
internalized to form foam cells, the hallmark of vulnerable atherosclerotic plaques [17]. The
inflammatory response for plaque formation is perpetuated through the release of cytokines,
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growth factors, metalloproteinase (MMP) and ROS, all playing a continued role in inducing
vascular remodeling and escalating the plaque’s susceptibility to rupture and likelihood of a
thrombotic event.
Figure 2.2: Image detailing the progression of atherosclerotic plaque to vulnerability. As a
necrotic core is increasingly remodelled, the plaque is prone to a thrombotic event, resulting in
a stroke or myocardial infarction. Image accessed from [20].
Nanoparticle contrast agents
The use of contrast agents in medical imaging is essential for soft tissue visualization. Materials
with a high atomic number (more than 40 protons in the nucleus) have unique x-ray absorp-
tion edges known as k-edges, which are within the diagnostic energy range. The energy of the
attenuation k-edge is characteristic for each element. Implementation of high-Z contrast agents
enables spectral imaging to detect and quantify biomarkers in soft tissue components that are
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low contrast, such as lipid [5].
Nanoparticles can be engineered for successful targeted labeling in imaging, overcoming
many biological, biomedical, and biophysical barriers [21]. One fundamental challenge is pack-
ing the nanoparticles in sufficient numbers for accurate distinction and quantification. Gold has
several advantages compared to iodinated contrast agents, achieving a contrast up to 3 times
greater than iodine per unit mass at ∼ 100keV. Additionally, gold nanoparticles have very low
viscosity and osmolality (number of moles of solute per kilogram of solvent), and carry more
gold atoms per molecules than iodine (250 atoms of Au compared of 3-6 atoms of iodine) [22].
These factors make gold a sought after radiopharmaceutical in research.
A past study employed gold containing HDL (Au-HDL) nanoparticles to visualize atheroscle-
rotic plaque in the abdominal aortas of apoE−\− mice using spectral CT [23]. Areas of high
attenuation were attributed to the accumulation of Au-HDL, which were found to largely local-
ize in macrophages. This high attenuation was observed in regions susceptible to atherosclerotic
plaque formation, such as the aortic arch, the region near the renal arteries, and the bifurcation
[24]. Colloidal gold has also been explored as a non-degradable marker joined to LDL’s, for
studying receptor binding and endocytosis. Conjugation of LDL to colloidal gold occurs by
electrostatic surface absorption due to the negative charge of the gold particle. As the col-
loidal gold is completely enclosed within a surrounding monolayer of LDL particles, it is easily
identified within the cell and presents a totally biological surface for cellular interaction [25].
Experiments tracking gold nanoparticles labeled to LDL particles have been successful in visu-
alising lipoprotein biointeractions in vitro and in a tumour mouse model [26]. It was shown that
Au-LDL expressed similar characteristics to native LDL in regards to size, morphology, compo-
sition, ApoB100 function, oxidation state, and molecular weight. With Au-LDL permitting the
uptake by macrophages, hepatocytes and a melanoma cell line in vitro through receptor depen-
dencies, the study supports the use of gold as a marker to study LDL interactions, cholesterol
metabolism, and atherosclerotic plaque progression [26].
2.3 Iodinated LDL experiment
2.3.1 Aim
In this experiment, the objective was to join a contrast agent such as iodine to low-density
lipoproteins (LDL’s), which could be visualized in the scanner as a result of the agent’s high
atomic properties. This experiment is significant because lipid is a low contrast material, mean-
ing it doesn’t observe an increase in attenuation through a k-edge, hence it is difficult to dis-
tinguish from other tissue-like components in conventional CT. Successfully joining a high-Z
material would allow lipid regions in atheromas with accumulated LDL to be enhanced using
spectral CT.
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2.3.2 Methods
A member of the MARS team undertaking their PhD in Biological Sciences prepared the LDL
samples in this study and following experiments.
Plasma was obtained from healthy donors under ethics approval CTY/98/07/069 granted
by the Upper South (B) Regional Ethics Committee. LDL was isolated from donor plasma us-
ing a centrifugation gradient separation method as described by Gieseg and Esterbauer (1994).
Isolated LDL was washed with phosphate buffered saline (PBS) using an Amicon Ultra-15 mem-
brane filter centrifugation tubes (Millipore, USA) at 3000 g, 4 C for 30 minutes, and repeated
twice. LDL concentration was adjusted to 10 mg (LDL total mass) per mL, which was de-
termined using a total cholesterol assay kit (Roche Diagnostics, Germany), assuming the total
cholesterol accounts for 31.69% of the LDL particle (MW 2500kDa).
This first attempt included prepared liquid and precipitated LDL samples that were either
in its native form (control) or iodinated (I-LDL). These were at a concentration of 10mg/ml
LDL, and the method used should have added 20 iodine atoms per LDL particle. The four PCR
tubes containing the LDL were ordered as follows:
• Liquid n-LDL (in phosphate-buffered saline (PBS)).
• Liquid I-LDL (in PBS. Iodinated the LDL using iodine monochloride).
• Pelleted n-LDL (pellets in 50% water, 50% trichloroacetic acid (TCA). Precipitated with
TCA).
• Pelleted I-LDL (pellets in 50% water, 50% TCA. Precipitated with TCA. Iodinated the
LDL using iodine monochloride).
(a) Iodinated phantom. (b) Iodinated LDL samples.
Figure 2.3: Iodinated LDL phantom with the iodinated LDL samples in liquid and pelleted
from. From left: liquid n-LDL, liquid I-LDL, pelleted n-LDL, and pelleted I-LDL.
The phantom contained these samples alongside standards for iodine at 9mg/ml and 18mg/ml
(I9 and I18), lipid, and water. The FactoryProtocol Al protocol was used, with an X-ray tube
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voltage of 118 kVp, tube current of 13µA, and exposure time of 300ms. The four energy bins
were set as 18.0 – 29.9 keV, 29.9 – 44.9 keV, 44.9 – 77.9 keV, and 77.9 keV - 118.0 keV.
2.3.3 Results and Analysis
To analyse the results from the scan, the reconstructed dataset labelled ‘RECON’ was down-
loaded from MARS Transfer. To identify the linear attenuation for each material in the phan-
tom, the dataset was loaded into ImageJ, where math processing was performed to generate
rescaled, 32-bit images. To initiate material decomposition (MD) of the dataset, the linear
attenuation values for the iodine standard concentrations and water across the four energy bins
were inputted into a Matlab code, which separated the water signal from the material to cal-
culate the material bases. The high-Z element and water material bases, along with the lipid
linear attenuation values, were saved in a config file, which was subsequently used to run the
MD with the reconstructed DICOM dataset.
Figure 2.4: Material decomposition of iodinated LDL phantom using MARS Vision. Iodine
signal is green, water is blue, and lipid is yellow.
By performing material decomposition on the reconstructed dataset, the above MARS Vi-
sion image was produced. The minimum threshold of iodine in the LUT setting was selected
as 0.009 to coincide with the lowest concentration of the iodine standard in the phantom at
9 mg/ml. By doing this, any iodine signal less then 9 mg/ml is eliminated, as it could be
considered a misclassification. This is supported by the misidentification chart produced, which
establishes 100% correct identification of I9 and I18 (Figure 2.5).
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Figure 2.5: Misidentification chart for the standards of iodine used in the iodinated LDL phan-
tom.
It was observed that at 10 mg/ml LDL, there was no measurable iodine signal in the liquid
LDL samples in its native (control) or iodinated form. This is evident in Figure 2.6, with the
spectral plot of the liquid I-LDL and liquid n-LDL samples having a trend similar to lipid. In
the precipitated LDL, both the native and iodinated samples revealed a significant iodine signal
not only in the pellet but also throughout the 50% water 50% TCA solution the pellets were
held in. In Figure 2.6, the pelleted samples have Hounsfield units closely following I9, but do
not exhibit the k-edge of iodine within the second energy bin, only showing a continued decrease
in HU across the four energy bins.
































Figure 2.6: Spectral plot for the iodinated LDL phantom.
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It was expected that an iodine signal would be detected in the I-LDL pellet alone, which
led to the conclusion that chlorine atoms in the trichloroacetic acid (TCA), used for precipita-
tion and was present within the solution that held the pellets, were responsible for the signal
throughout the tube. The calibration phantom only contained standards for iodine at 9 mg/ml
and 18 mg/ml, lipid, and water. A signal from the presence of chorine in the pelleted samples
would not express as lipid or water, and therefore must identify as an iodine signal. To avoid
this, all further precipitations were conducted using acetonitrile (ACN), with pellets held in air
in the PCR tubes.
2.3.4 Conclusion
In this experiment, the aim of joining iodine to LDL was met in the precipitated samples (both
native and iodinated). However, the samples prepared did not react as anticipated. Rather
than the pellets displaying an iodine signal alone, the chlorine in the TCA solution contributed
to the iodine signal. As a result of this finding, following experiments used pelleted samples
held in air, to eliminate any unnecessary signal from materials/solutions other than the pellets.
2.4 Gold, iodinated, and native LDL
2.4.1 Aim
Following from the results of the first LDL experiment using iodinated LDL in pelleted and
liquid form, a similar experiment was formulated with modification to the methodology. The
objective was to observe how gold and iodine join to LDL’s in pellets held in air, and verify
their ability as contrast agents to be identified in the material decomposition of the scan result.
The significance of this experiment enables joining of high-Z materials to LDL’s in optimal
conditions, allowing lipid, a low contrast material, to be enhanced using the MARS spectral
scanner.
2.4.2 Methods
Iodinated LDL (I-LDL) was prepared by gently mixing 500uL of 20mM ICl in 2M NaCl with
1 mL of 10 mg/mL LDL. This solution was washed using ultra membrane filter tubes. Native
LDL (n-LDL) was prepared in the same manner except with the addition of 500uL of PBS
rather than ICl. Gold nanoparticle labelled LDL (Au-LDL) was prepared by mixing 500uL
of 0.5 mg/mL AuNPs with 1 mL of 10 mg/mL LDL, a method modified from Handley, 1981
(Handley, Arbeeny, Chien, 1981). All solutions were filter sterilised through a 0.22 um filter
prior to use in cell culture. To form LDL precipitates; 500uL of acetonitrile (ACN) was added
to 500uL of LDL (native, iodinated or Au-labelled) in 1.7 mL eppendorf tubes and vortexed for
30 seconds. Precipitates were then centrifuged at 15,000 RPM for 10 minutes at 4 C to form
pellets. The ACN supernatant was then removed and the pellets were removed with care from
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the eppendorfs and placed into PCR tubes.
The phantom contained standards for gold at 4mg/ml and 8mg/ml, (Au4 and Au8), iodine
at 9mg/ml and 18mg/ml (I9 and I18), lipid, water, and the three PCR tubes containing the
10mg/ml pelleted LDL’s:
• Pelleted Au-LDL in air.
• Pelleted I-LDL in air.
• Pelleted n-LDL in air.
(a) Gold, iodine, and native-LDL phantom. (b) Au-LDL, I-LDL, and n-LDL pel-
lets.
Figure 2.7: Pictures of the gold, iodine, and native-LDL phantom. In (b), from left: Au-LDL,
I-LDL, and n-LDL pellet.
The scan was completed using the FactoryProtocol Al protocol using identical parameters as
in the iodinated LDL experiment. The energy bin range used (18.0 - 29.9 keV, 29.9 - 44.9 keV,
44.9 - 77.9 keV, and 77.9 keV - 118.0 keV) incorporated the k-edge of iodine at approximately
33.2 keV, and captures the attenuation of gold in the higher energy, representing its k-edge at
approximately 80.7 keV.
2.4.3 Results and Analysis
To optimise the MD image, the LUT minimum thresholds were set as 0.002 and 0.009 for
gold and iodine, respectively, in relation to their misidentification charts for correct material
classification at these concentrations (Figure 2.5) The following material decomposition of the
phantom was produced.
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(a) Gold, iodine, and native-LDL phantom. (b) Side view of gold, iodine, and native-LDL phantom.
Figure 2.8: Material decomposition of gold, iodine, and native-LDL pellets. Gold signal is
shown as gold, iodine as green, water as blue, and lipid as yellow (centre vial). In (b), the lipid
signal has been suppressed.
The spectral plot representing Hounsfield Units across the energy bins clearly displays the
increase in attenuation at the second energy bin, illustrating the k-edge of iodine. The gold
standards also show a small incline between the third and fourth energy bin, depicting the
k-edge of gold at 80.7 keV. Most notable is the pronounced signal from the I-LDL pellet, which
also follows the spectral profile of that of the iodine standards. In the second energy bin (29.9
– 44.9 keV) the I-LDL signal measures close to 4000HU, whereas the k-edge peak of the iodine
standard I18 measures just over 1000HU. The Au-LDL pellet possesses a signal slightly higher
than Au8. As expected, the control pellet containing LDL in its native form did not reveal any
Au or I signal, and maintained a spectral profile between water and lipid.

































Figure 2.9: Spectral plot for the Au-LDL, I-LDL and n-LDL phantom.
18 CHAPTER 2. LIPID
Using MARS Vision, the concentration of gold and iodine in the Au-LDL and I-LDL pellet,
respectively, was quantified by taking a measurement from an axial, coronal, and sagittal slice
using the polygon tool to select the region of interest.
(a) Axial slice. (b) Coronal slice. (c) Sagittal slice.
Figure 2.10: Polygon selections for axial, coronal, and sagittal slice in Au-LDL pellet.
Au in Au-LDL pellet Mean (mg/ml) Standard deviation No. of pixels
Axial 13.0207 3.54443 271
Coronal 14.5312 3.24986 257
Sagittal 14.4345 2.33171 280
Table 2.1: Quantity of gold in Au-LDL pellets, measured in an axial, coronal, and sagittal slice,
as seen in Figure 2.10.
(a) Axial slice. (b) Coronal slice. (c) Sagittal slice.
Figure 2.11: Polygon selections for axial, coronal, and sagittal slice in I-LDL pellet.
I in I-LDL pellet Mean (mg/ml) Standard deviation No. of pixels
Axial 65.0954 20.6237 192
Coronal 74.1821 19.0206 220
Sagittal 67.8592 22.6289 272
Table 2.2: Quantity of iodine in I-LDL pellets, measured in an axial, coronal, and sagittal slice,
as seen in Figure 2.11.
2.4.4 Conclusion
This experiment effectively joined gold and iodine to 10 mg/ml precipitated LDL, with the
material decomposition measuring a gold signal in the Au-LDL pellet in the range 13-14 mg/ml
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across axial, coronal, and sagittal slices. Iodine measurements produced a significant signal in
the I-LDL pellet, in the range 65-74 mg/ml across axial, coronal, and sagittal slices. The n-LDL
produced no gold or iodine signal as anticipated, displaying as water in the MD.
With the success of joining gold and iodine to precipitated LDL and observing a signal at
concentrations measurable using the MARS scanner, the experiment was translated to U937
cells, which are commonly used in research to study monocytic differentiation.
2.5 U937 cells with gold and iodinated LDL
2.5.1 Aim
The objective of this experiment, following the success of joining gold and iodine to 10mg/ml
precipitated LDL in Section 2.4, was to use the human macrophage cell line known as U937
cells to attempt to observe the uptake of Au-LDL and I-LDL within the cells. Through the high
atomic properties of the contrast agents, it is anticipated the MARS scanner will detect the
uptake of the gold and iodine from the cells. The significance of employing a human macrophage
cell line allows the amount of contrast taken up by the cells to more closely resemble the
mechanism of uptake in human cells in atherosclerosis progression.
2.5.2 Methods
The U937 cells were cultured in RPMI-1640 media containing 5% fetal bovine serum (FBS).
U937s were plated into 12 well plates (Nunc, Thermo Fisher Scientific, NZ Ltd) and differen-
tiated for 24 hours with the addition of 100 ng/mL of phorbol-12-meristate-13-acetate (PMA).
Cells were then treated with n-LDL, Au-LDL and I-LDL at a final concentration of 2 mg/mL
for 24 hours. The supernatant was then removed and the U937 cells were lifted from the plate
using 200uL of accutase. The resulting liquid was transferred to PCR tubes and the cells were
pelleted by centrifugation (1500 RPM, 5 minutes at 20◦C).
The U937 cell samples were scanned in a phantom containing standards for gold at 2mg/ml
and 4mg/ml (Au2 and Au4), iodine at 9mg/ml and 18mg/ml (I9 and I18), lipid, and water.
• Au-LDL U937 cells in air.
• I-LDL U937 cells in air.
• n-LDL U937 cells in air.
The scan was run using the FactoryProtocol Al protocol, with identical scan parameters to
previous LDL experiments.
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joined to U937 cells.
Figure 2.12: The phantom for the U937 cells experiment. In b), from left: Au-LDL with U937
cells, I-LDL with U937 cells, and n-LDL with U937 cells
2.5.3 Results and Analysis
The U937 cells were differentiated to be macrophage-like using PMA, after the addition of Au-
LDL and I-LDL. Initial observations of the pelleted U937 cells (2 million per pellet) revealed
very little colour change, suggesting poor uptake of the Au-LDL and I-LDL. As a result, it was
anticipated the cells might not produce a strong gold or iodine signal. It is noteworthy that the
maximum LDL concentration that could be added to the cells was 2 mg/ml, which is markedly
lower than the concentration used for the precipitates.
(a) Optimised MD image of the phantom for the
U937 cells experiment.
(b) MD image displaying gold and iodine signal
only.
Figure 2.13: Optimised MD images of the U937 cells experiment phantom. In (a), the gold
signal is shown in gold, iodine as green, lipid in yellow, and water as blue. In (b), the lipid and
water signals have been suppressed to show the high-Z channels only.
The images were optimised on MARS Vision, with the LUT minimum threshold set to 0.002
for gold and 0.009 for the iodine channel. Due to the insufficient amount of LDL that could be
added to the U937 cells, there was no gold or iodine contrast detected in the cell samples. This
is evident in Figure 2.13b, which shows a gold and iodine signal only as part of the gold and
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iodine standards.
The absence of contrast agent in the U937 cells is reflected in the spectral plot in Figure
2.14, which shows all three cell samples with signals especially close to water. They follow
water’s horizontal trend for the first three energy bins, with a decrease in attenuation below
that of water for the fourth energy bin. The iodine standards express their characteristic k-edge
profile in the energy range 29.9 – 44.9 keV, with an increase in attenuation apparent for the
gold standards in the energy range 77.9 keV <.
































Figure 2.14: Spectral plot for the experiment joining Au-LDL, I-LDL and n-LDL to U937 cells.
A possible rationale for the unsuccessful detection of contrast agents in the U937 cells might
be due to the uptake mechanisms of LDL. LDL is taken up in a regulated manner by the cells,
whereas oxidized LDL is taken up by scavenger receptors in a completely uncontrolled way. This
generally leads to foam cell formation. It may also be possible that the modification of LDL
means that it is no longer recognised by the LDL receptor on U937 cells, or the LDL uptake
is severely limited by the number of receptors available. For further LDL experiments, it may
be worth using ox-LDL rather than native-LDL, which may increase the uptake by the cells.
Another alternative is to look at increasing the number of iodine atoms or AuNPs per LDL, so
there is a higher concentration of contrast agent per protein, and hence a higher expectation of
detecting a signal if the rate of uptake remained the same.
2.5.4 Conclusion
The goal of observing the uptake of Au-LDL and I-LDL in U937 cells was unsuccessful due to
poor uptake of the contrast agent by the cells. Further experiments using ox-LDL rather than
native-LDL may increase the uptake and signal of the contrast agents. Discontinuing further
LDL experiments for this thesis, movement towards macrophage cell experiments could allow
the quantification of contrast agents within cell samples.
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2.6 Macrophage experiment
2.6.1 Aim
The aim of this experiment was to measure the quantity of gold nanoparticles (AuNP) in two
macrophage cell samples (one with serum and one without), and in their respective controls (cells
only, with no AuNP). The significance of this experiment relates to macrophages contribution
to necrotic core formation and plaque progression. The ability to visualise high contrast gold
nanoparticles in macrophage samples could translate to plaque imaging in patients for signs of
plaque vulnerability, such as necrotic core formation and fibrous cap thinning.
2.6.2 Methods
Primary cultures of human peripheral blood mononuclear cells (PBMC), which are a mixture
of lymphocytes and monocytes, were isolated from donated fresh whole blood under ethics
approval CTY/98/07/069. The mononuclear cells were prepared by density gradient centrifu-
gation over LymphoprepTM (Axis-Shield PoC AS, Oslo, Norway), as described by the man-
ufacturer, and washed in sterile phosphate-buffered saline (PBS) containing 150 mM sodium
chloride and 10 mM sodium dihydrogen orthophosphate pH 7.4. The cells were plated in 12-
well tissue culture plates (Nunc, ThermoFisher Scientific, Auckland, NZ) at 5 × 106 cells per
mL in Roswell Park Memorial Institute (RPMI)-1640 containing penicillin (100 U/mL) and
streptomycin (100 g/mL), supplemented with 10% human serum. Human monocyte-derived
macrophages (HMDM) were prepared from the PBMC preparation by incubating for 40 h in
serum-free RPMI before plating at 5×106 cells/well in RPMI-1640, as described for the PBMC,
except 3 µg/mL of granulocyte-macrophage colony-stimulating factor (GM-CSF) was added to
the media on the first day after plating but not added during subsequent media changes, which
occurred every 3 d. The monocytes differentiated into adherent macrophages over 7 to 14 d.
The cells were grown in the tissue culture plate, in RPMI1640 with 10% human serum. The
control cells were left in this for 24 hours and then the media was removed. 250uL of Accustase
was used to lift the cells off the plate, which were then transferred to a 1.7ml eppendorf and
centrifuged (2000rpm for 5 minutes) to generate a pellet. Any liquid was suctioned off with
a vacuum. The control cells without serum were cultured for 24 hours just with RPMI, and
pelleted the same method as the control cells containing serum. The cells with nanoparticles
were produced by firstly concentrating the particles 10x, then adding 100uL (10x dil) to either
RPMI only or RPMI with human serum. The nanoparticle concentration was about 150ug/ml.
The same technique as above was used to generate the pellet.
The phantom used for the scan contained standards for gold at 2mg/ml, 4mg/ml and 8mg/ml
(Au2, Au4, Au8), lipid, water, the macrophage cell samples and their controls.
• CH: Control (cells only, no AuNP), with human serum.
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• NH: Cells with Au nanoparticles, with human serum.
• C-H: Control, without human serum.
• N-H: Cells with Au nanoparticles, without human serum.
Figure 2.15: Picture of macrophage phantom containing standards for gold, lipid, water, and
the macrophage cell samples.
The MARS Spectral scanner was used to scan the phantom, using the FactoryProtocol Al
protocol. This protocol had scan parameters comprising an X-ray tube voltage of 118 kVp,
tube current of 13µA, and a 300ms exposure (acquisition) time per frame. The four energy bins
were specified as 18.0 – 29.9 keV, 29.9 – 44.9 keV, 44.9 – 74.9 keV, and 74.9 keV - 118.0 keV.
This energy range captures the attenuation of gold at the higher energies, representing gold’s
k-edge at approximately 80.7 keV.
2.6.3 Results and Analysis
The following images were produced by uploading the reconstructed dataset and material infor-
mation on MARS Vision. Using the Look Up Table (LUT) setting, the minimum threshold of
the Au signal was adjusted to 0.002 (equivalent to the lowest concentration of the gold standard
in the phantom at 2mg/ml). The Au and second energy bin (29.9 – 44.9 keV) are visible in
Figure 2.16b, as the lipid and water channels have been disabled. A strong Au signal can be
observed in the pellet containing cells with nanoparticles, without human serum.
(a) Optimised MD image of the
macrophage phantom.
(b) Optimised MD image display-
ing gold signal only.
Figure 2.16: Optimised MD image of the macrophage phantom. Gold is displayed as yellow,
lipid as a pale yellow/beige colour, and water as blue.
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Using MARS Vision, the concentration of gold in the pellet was quantified by taking a
measurement from an axial, coronal, and sagittal slice using the polygon tool to select the
region of interest (recorded in Table 2.3).
(a) Axial slice. (b) Coronal slice. (c) Sagittal slice.
Figure 2.17: Polygon selections for axial, coronal, and sagittal slice for macrophage sample
containing gold nanoparticles without human serum (N-H).
Slice from N-H sample Mean (mg/ml) Standard deviation No. of pixels
Axial 11.3728 7.797227 141
Coronal 10.9698 7.91263 96
Sagittal 11.9442 8.30049 87
Table 2.3: Quantity of gold in macrophages containing Au nanoparticles without human serum,
measured in an axial, coronal, and sagittal slice, as seen in Figure 2.17.
The decision to set the minimum threshold of the Au signal to 0.002 is consistent with the
percentage of misidentification in the standards of gold. In the following misidentification chart,
Au2 has a percentage of correctly identifying gold at 85%, water 15%, and lipid 0.2%. Correct
identification for gold above 80% detection for the lowest gold standard concentration instates
a confidence for correct material identification, and by setting the minimum threshold at 0.002,
eliminates areas identifying as gold, which can be classified as a misidentification.
Figure 2.18: Misidentification chart for gold concentrations.
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By modifying the Au signal displayed in MARS Vision to coordinate with the gold standards
in the phantom, there was a strong signal from the pellet containing cells with nanoparticles
without human serum, and no signal from the other three samples. This is observed in the
spectral plots, displaying the Hounsfield Units for each material across the four energy bins.
Hounsfield Units were used in the spectral plot, so that the linear attenuations were normalized
so water and air would yield the same value across the energy bins. Water at standard pressure
and temperature is defined as 0 HU, and air is defined to be -1000 HU. The cells containing
nanoparticles without human serum exhibit a HU signal between the gold standards Au4 and
Au8, whereas the control cells with human serum, and the cells with nanoparticles with human
serum demonstrate a signal close to water. The control cells without human serum have a trend
following that of lipid.

































Figure 2.19: Spectral plot for the macrophages gold nanoparticle phantom.
With gold being the primary focus of the macrophage experiment, it is important to select
the parameters for the scan that will best accommodate the spectral characteristics of this high
Z material. Gold has a k-edge of approximately 80.7 keV [27], and our fourth energy bin is in
the range of 74.9 keV - 118.0 keV. To potentially improve this experiment, the range of the
fourth energy bin could be increased to better incorporate gold’s k-edge, or adding a fifth energy
bin to encompass the k-edge fully.
2.6.4 Conclusion
The goal of quantifying the amount of gold in macrophage cell samples was successful in the
pellet containing cells with gold nanoparticles, without human serum. In the material decom-
position, axial, coronal, and sagittal slices measured a quantity of gold signal in the range of
10-11mg/ml. To optimise this experiment further, optimising the energy bins in the protocol
used would incorporate gold’s k-edge effectively, potentially improving the analysis of the gold
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spectral signal.
2.7 Summary
To summarise the key points of this chapter:
• The governing role of lipoproteins is to transport lipids such as cholesterol and triglycerides
around the body in the extracellular fluid, facilitating the availability of fats to cells via
receptor-medicated endocytosis.
• Low-density lipoproteins (LDL’s) are deemed pro-atherogenic, as oxidized forms invad-
ing the endothelium become more easily retained by proteoglycans, hence promoting
atherosclerosis progression and vulnerable plaques susceptibility to rupture.
• The use of high-Z material based exogenous contrast agents such as gold and iodine are
an essential tool for categorizing soft tissue biomarkers of vulnerable plaque within the
human imaging energy range (20 – 120 keV). All atoms have a unique x-ray absorption
edge known as a k-edge. Some high atomic materials are within the diagnostic energy
range, enabling them to detect and quantify low contrast materials such as lipid.
• The pelleted iodinated and native LDL samples were affected by the chlorine atoms in the
trichloroacetic acid (TCA) used for precipitation, which resulted in the misidentification
of iodine throughout the PCR tube.
• Pelleted I-LDL and Au-LDL in air at 10mg/ml-precipitated LDL produced a significant
signal at concentrations measurable using the MARS Vision software.
• The use of U937 cells resulted in poor uptake of the Au-LDL and I-LDL, as observed
by the very minimal colour change of the pelleted cells. This may be due to the uptake
mechanisms of LDL, which is a more regulated process compared to the uptake of ox-LDL.
• The macrophage cell sample of the pellet containing cells with nanoparticles without
human serum displayed a strong gold signal in the MARS Vision software, with the




The aim of this chapter was to distinguish iron and calcium using spectral CT by optimising
a scanning protocol and phantom with iron- and calcium- like materials. The significance of
the experiments set out in this chapter includes the long term goal of scanning atheromas to
visualise intraplaque haemorrhage and calcifications accurately. The coexistence of iron and
calcium in atherosclerotic plaque provides an interesting challenge for imaging modalities, with
both materials possessing similar spectral profiles. Iron is an important component of vulnerable
plaques due to the feature of intraplaque haemorrhage. Calcium can both prevent and progress
plaque vulnerability. Large calcified regions provide plaques with stability, while microcalcifi-
cations indicate destabilisation of the atheroma. The ability to distinguish iron and calcium is
investigated through multiple phantom studies, with the aim of optimising a phantom suitable
for visualising intraplaque haemorrhages and calcifications within vulnerable plaques.
Section 3.2 introduces iron and calcium, and the role they play in vulnerable plaque pro-
gression. Previous studies demonstrating the identification of these materials is detailed, along
with evidence of their relationship with other components of atheromas. Section 3.3 describes
the experiment using large ferric nitrate concentrations, while section 3.4 implements the use of
small ferric nitrate concentrations. Section 3.5 attempts to optimise the ferric nitrate phantom
(large concentrations) using two different scanning protocols. The ability of iron to have a
predominate signal over calcium is investigated in section 3.6, with the blood clot experiment
described in section 3.7. A summary of the chapter is given in section 3.8.
3.2 Iron and calcium in atherosclerosis
Intraplaque haemorrhage
The study of iron and calcium is consequential to understanding the mechanisms that support
the progression of vulnerable atherosclerotic plaques. Intraplaque haemorrhage is a common
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identifying feature of complex lesions leading to acute ischaemic events, which arises from a
disruption of thin-walled microvessels, resulting in erythrocytes (red blood cells) leaking into
the plaque [28]. Induced is macrophage infiltration and erythrophagocytosis, which prompts
intracellular deposits of iron from the erythrocytes haemoglobin content. The leakage of ery-
throcytes often instigates coagulation, forming a delicate mesh network of fibrin fibers. Thus,
the occurrence of intraplaque haemorrhage can be defined by the presence of fresh or lysed
erythrocytes, iron deposits in macrophages, and/or a fibrin clot [29].
The relevance of the iron component of intraplaque haemorrhage transpires from the haemoglobin
contained in erythrocytes. Haemoglobin is the iron-containing metalloprotein responsible for
oxygen and carbon dioxide transport between the lungs and tissues. A haemoglobin molecule
consists of four haem groups surrounding a globin group, which consists of two alpha-globin
chains and two beta-globin chains. Embedded within the haem compound is an iron ion (charged
atom), which is the site of oxygen binding and is gives blood its red colour. Collectively, the
four haem groups per haemoglobin molecule can bind four oxygen molecules.
Figure 3.1: Haemoglobin molecule. Accessed from [30].
Iron regulation
Iron is an essential biometal in human physiology, but is potentially hazardous due to the toxic-
ity of free iron ions. For this reason, the vast majority of iron in the body exists in bound form,
with effective iron regulation mechanisms to satisfy the metabolic needs of cells. A large part
of body iron, approximately 2500mg, is distributed in erythrocyte haemoglobin, while 1000mg
is present within ferritin in specific storage tissues such as the liver and spleen. Approximately
170mg is stored in skeletal muscle myoglobin, with 3mg of iron circulating in the transport
protein transferrin [31]. Although electron transfer between iron ions is essential for iron trans-
portation, use and storage, it also allows free irons to form highly reactive free radials that can
lead to cell damage [32]. Fe2+ is involved in iron-induced oxidative stress through the creation
of highly reactive hydroxyl radicals, contributing to the formation of insoluble fibrin clots [31].
Fe3+ on the hand is rather bio-unavailable due to its poor solubility. As iron readily shuttles
between the reduced ferrous (Fe2+) and the oxidised ferric (Fe3+) forms, maintaining successful
iron regulation is paramount [33].
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Iron is transported around the body bound to transferrin, with each transferrin protein
binding two iron atoms. A large part of this iron is taken up by developing erythrocytes within
the bone marrow, and incorporated into the production of haemoglobin [32]. Old or damaged
erythrocytes are removed from the bloodstream by the macrophages of the reticuloendothe-
lial (RE) system, where the iron is liberated from haemoglobin to be stored in ferritin, the
intracellular iron storage protein, or released back into the bloodstream as transferrin-bound
iron.
Calcifications
The role calcifications play has shifted in the way atherosclerotic lesions are interpreted. Cal-
cification is a common feature of atherosclerotic plaques, and is easily recognised due to the
high resolution of computed tomography. A study evaluating individual plaques revealed an
ischaemic event was more likely in plaques that were noncalcified rather than calcified. The
new theory suggests that calcium may defend against plaque destabilisation by creating a region
of mechanical stability at the interface between calcified and non-calcified plaque [34]. Calci-
fications may also stabilise plaque by excluding intra-lesion iron that has a higher likelihood
of contributing to a thrombotic event [35]. By using three ion-beam techniques to spatially
map iron and calcium simultaneously within lesions, Rajendran et al. revealed a spatial inverse
correlation, suggesting iron may simultaneously accelerate the progression of atherosclerotic
plaques while suppressing calcium. Alternatively, calcification could be a defense mechanism
that protects against large accumulations of localised iron.
In the same mindset, more insignificant calcifications that are seemingly harmless may con-
tribute to plaque destabilisation. It is hypothesised that spotty calcification (>30µm) may be
an indication of active remodeling, while microcalcifications (1µm - 30µm) cause plaque insta-
bility by promoting stress accumulation within the ECM. Cavitation results due to mismatch
between the small, stiff microcalcifications and the surrounding collagen medium [36]. As mi-
crocalcifications develop to large macrocalcifications that form beneath the thick fibrous cap, it
is suggested that the vascular atherosclerotic plaque increases in stability [37].
Intraplaque haemorrhage association with lipid deposition
Numerous atherosclerosis studies have investigated the relationship between iron and calcium
and their association with other materials in vulnerable plaques. Especially apparent is the
role intraplaque haemorrhage holds in contributing to local lipid deposition, acting as a source
for proinflammatory responses [38]. The leakage of erythrocytes could lead to increased choles-
terol deposition and plaque destabilisation. With this knowledge, the cholesterol content in
erythrocytes could be a marker for the progression of atherosclerotic plaque and an indicator
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of vulnerability [39].
Extravasated erythrocytes constitute the main cellular component of intraplaque haemor-
rhage [39], and therefore promote cholesterol accumulation and oxidative stress through their
makeup of haemoglobin and rich unesterified cholesterol. Erythrocytes lyse quickly within the
highly oxidative environment of atherosclerotic plaques, giving haem and iron the ability to
modify lipids through oxidation and cause endothelial cytotoxicity [40]. Through this process,
haem and iron amplify the oxidative capacity of the plaque and therefore participates in lipid
deposition and necrotic core expansion upon intraplaque haemorrhage [41].
Research has also suggested erythrocytes contribute to the additional mechanism of foam
cell formation. One study demonstrated haemoglobin, haem oxygenase-1, and iron in the cy-
toplasm of macrophages around microvessels in specific plaque regions rich in lipid [42]. This
indicated microhaemorrhages and subsequent phagocytosis of platelets and erythrocytes. An-
other study injected erythrocytes into inactive aortic atherosclerotic plaques, which displayed
excessive macrophage infiltration [43]. Collectively, these studies suggest that erythrophago-
cytosis leads to iron deposition within macrophages and macrophage activation, promotion
of ceroid production, and accelerated foam cell formation by increasing the capacity of the
macrophage to oxidise LDL [44][45].
Interest has been shown in glycophorin A, a characteristic protein of erythrocytes that facili-
tates anion exchange. Kolodgie et al. demonstrated that the degree of reactivity of glycophorin
A and the amount of accumulated iron corresponded to the size of the necrotic core. This
was achieved by grading stained specimens based on the percentage of necrotic core or lipid
made up of glycophorin A and iron [43]. Colocalisation of glycophorin A and lipid in necrotic
cores, paralleled with the increase in the density of macrophages, suggests cholesterol crystals
within the plaques could originate from erythrocytes phagocytised by macrophages [39], with
intraplaque haemorrhage serving as an inflammatory stimulus.
Quantification of iron in the presence of calcium
The ability to identify and quantify iron from calcium deposits in plaques relies heavily on the
ability of the scanner to accurately discern materials. With iron and calcium not having a
k-edge within the diagnostic energy range, single-energy x-ray alone cannot distinguish Fe and
Ca. At the spatial resolution of interest, conventional CT scanners are limited by partial vol-
ume effects due to the large detector pixel size compared with the small haemorrhage deposits
seen in human atherosclerotic plaque (10µm3 to 100µm3) [46]. By implementing dual-energy
computed tomography and synchrotron-based micro-CT, previous studies have been able to
utilise the different x-ray photon energy-dependent attenuation coefficients in an attempt to
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distinguish these materials.
The first study employed a clinical dual-energy CT (DECT) scanner to quantify iron in the
presence of calcium in an ex vivo porcine arterial plaque model. Mixture solutions of known iron
and calcium concentrations were prepared to calibrate the DECT-based algorithm [33]. Iron-
and calcium- specific staining was carried out on histological sections to support the co-existence
of iron and calcium in the simulated plaques, with a sensitivity of 83% and specificity of 92%
demonstrated for iron detection using a threshold at an iron mass fraction of 0.25%. Some
voxels of calcium-only plaque gave a positive iron signal, this being attributed to image noise
and partial volume effect. The partial volume effect occurs when there is more than one ma-
terial occupying a CT voxel, resulting in an attenuation coefficient proportional to the average
value of these materials. Material boundaries are blurred to some extent due to the resolution
limitations of CT, and so a material in any one voxel can affect the attenuation coefficient of
surrounding voxels. This may lead to misclassification, as observed for the calcium-only plaque.
The iron quantity calculated in plaques with only iron or iron and calcium mixture solutions
however was notably higher (p = 1.21 ×10−4) [33].
With the co-existence of iron and calcium deposits in atherosclerotic plaque, finding the point
at which there is enough iron present in a voxel that its signal predominates, and predominates
over every other signal, has lead to studies quantifying the amount of iron and calcium per
voxel, and evaluating the influence of voxel size in distinguishing iron and calcium deposits. For
analysis of the spatial distribution of Fe and Ca, Langheinrich et al. used synchrotron-based
micro-CT imaging, in addition to a synchrotron-based x-ray fluorescence microscopy, to localise,
identify, and quantitate regions of intraplaque haemorrhage and its consequences relating to
calcifications [46]. Images at 2µm voxel resolution of the descending aortic walls revealed local
accumulations of punctate bright spots (∼ 8µm diameter), corresponding to iron deposits.
CT opacities were identified as haemorrhage-related clusters of multiple punctate deposits,
containing both Fe (0.48×10−12 g/voxel) and Ca (3.18×10−2 g/voxel), or isolated accumulations
of exclusively calcium. Based on the haemoglobin content of 1 erythrocyte, the iron content of 1
erythrocyte was estimated at 0.24×10−12g [46]. A second study by Langheinrich et al. evaluated
the influence voxel size had on discriminating calcium from iron deposits in ex vivo coronary
arteries, using clinical CT and synchrotron micro-CT. An advantage micro-CT has over clinical
CT is its ability to generate voxels small enough to essentially eliminate the partial volume
effect. Using synchrotron micro-CT, images at 4µm voxel size revealed local accumulations of
punctate bright spots, consistent with iron deposits from individual extravascular erythrocytes
[10]. The bright spots were spatially separate from calcifications. Iron deposits were visualised
using the greyscale values using synchrotron-based micro-CT up to 12µm voxel size. Images
with voxels greater than 20µm resulted in sufficient blurring of the punctate bright spots [10],
as a consequence of the partial volume effect. By virtue of the greyscale values the iron deposits
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could not be distinguished from the calcifications.
3.3 Ferric Nitrate experiment (large concentrations)
3.3.1 Aim
The aim of this experiment was to investigate the material decomposition of a phantom con-
taining samples corresponding to iron (ferric nitrate), calcium (hydroxyapatite), and iodine.
The MARS spectral scanner currently has difficulty distinguishing iron and calcium, due to the
materials similar spectral profiles. Neither material has a k-edge within the energy region of
interest for diagnostic imaging, with Fe and Ca having an X-ray absorption edge of 7.11 keV
and 4.01 keV, respectively. For this reason, it is hypothesized that the two materials will not
be distinguishable. The significance of discriminating these materials would provide the MARS
Spectral scanner with the ability to image and visualise iron and calcium simultaneously in
atherosclerotic plaques, contributing to the long term goal of scanning patients who are more
susceptible to a stroke or myocardial infarction.
3.3.2 Methods
A Biological Sciences PhD student prepared concentrations of ferric nitrate by making up a
1g/ml solution of ferric nitrate in water and then using that stock solution to produce each
concentration in individual PCR tubes. The accuracy for the amount of ferric nitrate in each
vial was provided from a rough error calculation based on pipetting and weighing out the ferric
nitrate at ∼ 3%. The five samples prepared for the phantom were at concentrations of 25mg/ml,
50mg/ml, 100mg/ml, 200mg/ml, and 400mg/ml. Included in the phantom were standards for
calcium at 104.3 mg HA/cm3 (HA100), 402.3 mg HA/cm3 (HA400), and 603.3 mg HA/cm3
(HA600), standards for iodine at 9mg/ml and 18mg/ml (I9 and I18), lipid and water.
(a) Ferric nitrate phantom
using large FN concentra-
tions.
(b) Ferric nitrate samples (large concentrations).
Figure 3.2: Ferric nitrate phantom using large FN concentrations. In (a), a birdseye view of the
phantom. In (b), the ferric nitrate concentrations (from left): 25mg/ml, 50mg/ml, 100mg/ml,
200mg/ml, and 400mg/ml.
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A new protocol named FerricNitrate Protocol@80kVp was developed for this scan and future
ferric nitrate studies. The scan parameters were defined with a tube voltage of 80kVp, tube
current of 55µA, and an exposure time of 100ms. The filtration used was 2mm Al, with four
energy bins specified as 20 – 27.9 keV, 27.9 – 35.9 keV, 35.9 – 43.9 keV, and 43.9 - 80.0 keV.
3.3.3 Results and Analysis
The MARS Vision material decomposition revealed indisputable misidentification between the
FN400 sample and the standard for HA100. From this observation, further analysis was per-
formed on these two samples, including a review of the materials’ linearity and spectral plots,
quantified MD analysis, material misidentification charts, and new methods implemented to
utilize the energy information from the scan in the hope of demonstrating separation between
the two samples in question.
Figure 3.3: Material decomposition ferric nitrate phantom (large concentrations) using MARS
Vision. Ferric nitrate signal is red, hydroxyapatite is white, iodine is green, water is blue, and
lipid is a cream/beige colour.
Energy image analysis
The following linearity and spectral plots were produced for the ferric nitrate and hydroxyap-
atite concentrations. The linearity plot shows the linear trend of the four energy bins across
the material concentrations. The linear attenuation values for each material concentration were
converted in Hounsfield Units (HU) to allow the linear attenuation values to be normalized so
water and air would yield the same value across the energy bins, and were separated into their
corresponding energy bins. The data points for the four energy bin plots were each accompanied
by a linear polynomial fitted to the data using Matlab’s inbuilt polyfit function. The linearity
plots are related to the spectral plots, which show the spectral profiles of the materials by dis-
playing their linear attenuation across the energies. An increase in attenuation at a particular
energy on the spectral plot, representing the k-edge of a material, would be expressed as a linear
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line displaying this increased HU signal across the material concentrations on the linearity plot.
The spectral plot for the ferric nitrate concentrations revealed an increase in attenuation
within the second energy bin, suggesting k-edge absorption of iron in the range 27.9 – 35.9 keV.
This spike is depicted by the increased linear trend for the second energy bin in the linearity
plot. The k-edge absorption of Fe is 7.11 keV, which contradicts the spectral profile of the ferric
nitrate samples observed here. The same circumstance is displayed in the spectral and linearity
plots for the hydroxyapatite concentrations. The k-edge absorption of Ca is 4.01 keV, so the
spectral plot is expected to have its increased attenuation within the first energy bin in the
range 20.0 – 27.9 keV, and then a gradual and continuous decrease in the HU signal across the
energies. As a result, the linearity plot reveals an increased linear trend in HU for the second
energy bin.
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(a) Linearity plot for FN samples in the ferric nitrate
phantom.




























(b) Spectral plot for FN samples in the ferric nitrate
phantom.
Figure 3.4: Linearity and spectral plot for the FN samples in the ferric nitrate phantom.
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(a) Linearity plot for the HA standards in the ferric
nitrate phantom.


























(b) Spectral plot for the HA standards in the ferric
nitrate phantom.
Figure 3.5: Linearity and spectral plot for the HA standards in the ferric nitrate phantom.
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Interpreting these plots, the issue could be a consequence of the energy intervals used for the
energy bins. The intervals are below 10 keV in width, which may lead to low energy photons
combining energy and being detected within the higher energy bin. It may also be a calibration
issue in relation to the camera, as the MARS scanner underwent maintenance prior to this scan
to update the single-chip camera to a three-chip camera.
Material decomposition results
The reconstructed dataset and the material folders generated from the MARS MD were inputted
in the MARS Vision software to view the phantom and the material identification. To measure
the quantity of material within a sample, a region of interest was created using the polygon tool.
The average amount of material measured in the ROI and its standard deviation could be used
to compare against the true concentrations of the materials, which are the known variables.
For ferric nitrate and hydroxyapatite, these quantified MD results were plotted as shown. Both
materials are in close correspondence to the true concentrations, which is represented by the
linear line that follows the increase in material concentration for the measured concentrations
and the known (given) concentrations. This result supports the calibration of the phantom, with
the MD results giving an accurate quantification for the amount of material in the samples.
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Quantifying Ferric Nitrate signal from MD results
R2 = 0.99116
(a) Plot quantifying the ferric nitrate signal from MD
results.
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Quantifying HA signal from MD results
R2 = 0.99933
(b) Plot quantifying the hydroxyapatite signal from the
MD results.
Figure 3.6: Quantification of the (a) ferric nitrate and (b) hydroxyapatite signal from the MD
results. The diagonal line acts as a reference line to represent the linear trend the datapoints
should follow for accurate MD quantification.
Misidentification charts were generated to identify what materials were being misclassified
in other material samples, and to determine the quantity of this misclassification. If a material
at a certain concentration has significant misidentification, the sample cannot be regarded as
reliable for correctly identifying the material with accuracy acceptable for the imaging chain.
As observed in Figure 3.7a, there is nearly 80% correct identification for the ferric nitrate
concentration 100mg/ml. FN200 has correct ferric nitrate identification of ∼ 75%. The ferric
36 CHAPTER 3. IRON VS. CALCIUM
nitrate concentrations FN25 and FN50 exhibit less correct identification due to their reduced
concentration and thus their susceptibility for other materials in the phantom to overwhelm
the ferric nitrate sample with their signal. Also observed is a significant HA signal in the
FN400 sample. The misidentification chart for the hydroxyapatite concentrations in Figure
3.7b shows an immense misclassification of ferric nitrate in the HA100 sample, with the ferric
nitrate signal predominant over the hydroxyapatite signal. HA400 and HA600 have correct
percentage identification of ∼ 93% and ∼ 100%, respectively. From Figure 3.3 displaying the
MD image, the misidentification established in these charts directly relates to the optimized
MD image and the mismatch of colours seen across the various samples.
(a) Misidentification chart for the ferric nitrate concentrations in the ferric nitrate phantom.
(b) Misidentification chart for the hydroxyapatite concentrations in the ferric nitrate phantom.
Figure 3.7: Misidentification charts for ferric nitrate (a) and hydroxyapatite (b) concentrations
in the phantom.
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New methods
The outcome of the ferric nitrate MD image from the visible misidentification between FN400
and HA100 instigated the implementation of new methods to assist in distinguishing these two
samples. By using the spectral information from the attenuation coefficients measured from
each energy bin, exploitation of the x-ray photons attenuation at different x-ray energies can
allow materials to be differentiated through their differing spectral profiles. The new methods
implemented were as follows:
• Histogram method
• ROC curves
• Percentage Correct (PC)
• Scatter plots with marginal histograms
Histogram method
Image processing was completed using ImageJ, which involved taking the average intensity
across ten slices and selecting a ROI for FN400 and HA100. The coordinates of the ROI, and
the associated attenuation coefficient of each pixel included within the ROI, were saved using
the ImageJ commands Analyze – Tools – Save XY Coordinates. This was done for each energy
image in ImageJ. By saving the coordinate information of the ROI in an excel spreadsheet for
each material at each energy, and importing the data for both materials into Maltab, histograms
comparing the attenuation coefficients of FN400 and HA100 across the four energy bins were
generated. These are accompanied by corresponding ROC curves below.
ROC curves
A receiver operating characteristic curve, abbreviated to ROC curve, is a graphical plot that is
a fundamental tool for diagnostic test evaluation. The four possible outcomes of a diagnostic
test include:
• True positive = correctly identified
• False positive = incorrectly identified
• True negative = correctly rejected
• False negative = incorrectly rejected
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To define the statistical measures of sensitivity and specificity that incorporates these possible
outcomes:
• Sensitivity measures the proportion of true positives that are correctly identified as such
by the test.
Sensitivity =
no. of true positives
no. of true positives + no. of false negatives
• Specificity measures the proportion of true negatives that are correctly identified as such
by the test.
Specificity =
no. of true negatives
no. of true negatives + no. of false positives
The ROC curve is created by plotting the true positive rate (sensitivity) against the false
positive rate (1-specificity) at various threshold settings across a diagnostic test. It is named
as such because it is a comparison of two operating characteristics (the true positive rate and
false positive rate) as the criterion changes. Each point on the ROC curve represents a sen-
sitivity/specificity pair that corresponds to a particular decision threshold. As the threshold
moves along the dataset for the first and second material, the sensitivity/specificity pairings
are calculated and plotted against the two operating characteristics. The area under the ROC
curve (AUC) determines how well a parameter can distinguish the two datasets. An area of
1 represents perfect discrimination, where there is no overlap in the two distributions of the
datasets. This is depicted by the ROC curve passing through the upper left corner of the ROC
space (100% sensitivity, 100% specificity). An area of 0.5 represents a worthless test, where
there is complete overlap between the two distributions, leading to no suggestion of discrimina-
tion being observable. This is illustrated by the ROC curve making a 45-degree diagonal across
the ROC space. Hence, the closer the curve traces the left hand border and the top border of
the ROC space, the more accurate the test.
With the ROI datasets for FN400 and HA100 for the four energy bins imported into Matlab,
the histograms and corresponding ROC curves were generated.
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Histogram for Energy 1 HA100 and FN400 ROI





































ROC Curve for HA100 and FN400  E1: 20.0-27.9keV
AUC =0.99531
Histogram for Energy 2 HA100 and FN400 ROI





































ROC Curve for HA100 and FN400  E2: 27.9-35.9keV
AUC =0.99281
Histogram for Energy 3 HA100 and FN400 ROI





































ROC Curve for HA100 and FN400  E3: 35.9-43.9keV
AUC =0.99383
Histogram for Energy 4 HA100 and FN400 ROI





































ROC Curve for HA100 and FN400  E4: 43.9keV <
AUC =0.99361
Figure 3.8: Histogram plots comparing HA100 and FN400 for the four energy bins. These
are accompanied by corresponding ROC curves for each energy bin. See section 3.3.3 for an
explanation of histogram plots and ROC curves.
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The histogram plots and corresponding ROC curves for HA100 and FN400 show clear dis-
tinction between the material’s linear attenuation values across the four energy bins. The
ROC curves have an Area Under the Curve approximately equal to 1, demonstrating complete
separation of HA100 and FN400 using the histogram method.
Percentage Correct (PC)
To further support the discrimination of the FN400 and HA100 datasets, the percentage of
correct identification was calculated. This was achieved by taking a number of trials; in this
case the number of trials was equivalent to the number of pixels with the ROI dataset at 2472
pixels. Knowing that the HA100 sample has lower attenuation values compared to FN400 in
the histogram plots, the trials ran through datasets, comparing a random value from the HA100
dataset and FN400 dataset. If the selected value from HA100 was smaller then the FN400 value,
a count was added to an empty array collecting all the instances of correct localization of the
pixels attenuation. For the four energy bins, the following PC values were calculated. These
values directly relate to the discrimination observed in the histograms and corresponding ROC
curves.
E1 E2 E3 E4
Percentage Correct 0.9972 0.9956 0.9915 0.9968
Table 3.1: Calculated PC values for the four energy bins.
Scatter plots with marginal histograms
Scatterplots were generated to visualize the relationship of the attenuation coefficients between
the energies. By comparing Energy bin 1 vs. Energy bin 2, Energy bin 2 vs. Energy bin 3, and
Energy bin 3 vs. Energy bin 4, a positive correlation is observed for the energies. Included in
these scatterplots are the marginal distributions of the energy bin on the x-axis and energy bin
on the y-axis as univariate histograms.
3.3.4 Conclusion
The material decomposition in Figure 3.3 revealed misclassification between FN400 and HA100.
By implementing new methods for analysis, such as the histogram method (which is basically
‘visual PCA’ - see chapter 4), ROC curves, PC, and scatter plots, the energy information from
the attenuation coefficients of FN400 and HA100 enabled the two material concentrations to
be separated. In the ferric nitrate samples 25mg/ml - 200mg/ml, a clear FN signal is observed,
with HA400 and HA600 showing a strong HA signal. The success of this experiment lead to
further ferric nitrate phantom experiments, trialing different concentrations of ferric nitrate and
hydroxyapatite in order to optimise the phantom for continued use in future phantom studies.
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Scatter plot with marginal histograms for Energy bin 1 and Energy bin 2
HA100
FN400
(a) Scatter plot comparing Energy 1 and Energy 2 attenuation coefficients.
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Scatter plot with marginal histograms for Energy bin 2 and Energy bin 3
HA100
FN400
(b) Scatter plot comparing Energy 2 and Energy 3 attenuation coefficients.
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Scatter plot with marginal histograms for Energy bin 3 and Energy bin 4
HA100
FN400
(c) Scatter plot comparing Energy 3 and Energy 4 attenuation coefficients.
Figure 3.9: Scatter plots with marginal histograms for E1 vs. E2, E2 vs. E3, and E3 vs. E4.
See an explanation on the previous page in section 3.3.3.
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3.4 Ferric Nitrate experiment (small concentrations)
3.4.1 Aim
The aim of this experiment was to investigate the material decomposition of a phantom con-
taining samples of ferric nitrate to represent iron, and standards of hydroxyapatite to represent
calcium. This experiment employed small ferric nitrate concentrations compared to the experi-
ment in Section 3.3. The significance of this is to use concentrations that more closely represent
concentrations of iron found in the human body. The small concentrations will test the MARS
scanner resolution and ability to accurately detect such low concentrations.
3.4.2 Methods
Following the results from the first experiment, smaller ferric nitrate concentrations were pro-
duced using the same methodology as in Section 3.3.2. Six samples were prepared at con-
centrations of 1mg/ml, 2mg/ml, 4mg/ml, 6mg/ml, 8mg/ml, and 10mg/ml, with the intent of
more closely representing anatomically relevant concentrations of blood in the body. The phan-
tom included standards for calcium at 104.3mg HA/cm3 (HA100), 211.7mg HA/cm3 (HA200),
402.3mg HA/cm3 (HA400), and 603.3mg HA/cm3 (HA600), lipid and water.
(a) Ferric nitrate phan-
tom using small FN con-
centrations.
(b) Ferric nitrate samples (small concentrations).
Figure 3.10: Ferric nitrate phantom using small FN concentrations. In (a), a birdseye view of
the phantom. In (b), the ferric nitrate concentrations (from left): 10mg/ml, 8mg/ml, 6mg/ml,
4mg/ml, 2mg/ml, and 1mg/ml.
The scan was run twice, first with the FerricNitrate Protocol@80kVp protocol and then with
the UOC Protocol Aluminium protocol, which is implemented in Chapter 6 for plaque scan-
ning. The purpose of scanning using both protocols was to attempt to merge the two together,
in a way that would allow future iron studies for intraplaque haemorrhage and calcium deposits
in plaque specimens to be investigated.
The FerricNitrate Protocol@80kVp protocol had equivalent scan parameters as in Section
3.3, although the four energy bins were specified in 10 keV intervals, at 20.0 – 30.2 keV, 30.2 –
40.1 keV, 40.1 – 49.8 keV, and 49.8 keV - 80.0 keV. This was especially important for the first
energy bin, to resolve the issue with the spectral plot of HA showing an increase in attenuation at
the second energy bin. The UOC Protocol Aluminium protocol had scan parameters including
3.4. FERRIC NITRATE EXPERIMENT (SMALL CONCENTRATIONS) 43
a tube voltage of 118 kVp, tube current of 23µA, exposure time of 100ms, and a 2mm Al
filtration. The four energy bins were in the range 30.0 – 39.9 keV, 39.9 – 50.0 keV, 50.0 – 60.0
keV, and 60.0 keV - 118.0 keV.
3.4.3 Results and Analysis
The reconstructed datasets for both protocol scans were loaded from MARS Transfer, and image
processing was completed to produced rescaled, 32-bit images. The attenuation coefficients were
recorded for each sample in the phantom by taking the average intensity over 10 slices. The 10
slices chosen for measurement were identical for both protocol scans. These values were inputted
into Matlab code to calculate the bases, which were then saved to a config file and used to run
the material decomposition with the reconstructed datasets. The FerricNitrate Protocol@80kVp
protocol MD ran successfully, however the MD for the UOC Protocol Aluminium protocol had
issues relating to its bases calculation. When the material bases were calculated, the ferric
nitrate bases for energy bin 2 (39.9 - 50.0 keV) and energy bin 3 (50.0 - 60.0 keV) were zero,
and when the linear attenuation values were converted to Hounsfield Units, all the HU were
negative values, indicating that the ferric nitrate signal was presenting less than that of water
(HU = 0). Although the MD ran successfully for the UOC Protocol Aluminium protocol, the
results from the MD were unproductive and did not display ferric nitrate signal in the FN
samples. Consequently, the following analysis is only from the ferric nitrate phantom run with
the FerricNitrate Protocol@80kVp protocol.
The following MD image was produced in MARS Vision. The minimum threshold of hydrox-
yapatite in the LUT setting was selected as 0.05 to coincide with correct material identification
of HA at ∼ 80% for HA50. By doing this, any HA signal <50mg/ml showing up elsewhere in
the phantom was eliminated, as it could be considered a misidentification.
Figure 3.11: Material decomposition ferric nitrate phantom (small concentrations) using MARS
Vision. Ferric nitrate signal is red, hydroxyapatite is white, water is blue, and lipid is yellow.
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Energy image analysis
The following linearity and spectral plots were produced for the ferric nitrate and hydroxyapatite
concentrations from the FerricNitrate Protocol@80kVp protocol scan. It is observed that the
ferric nitrate concentrations (1mg/ml - 8mg/ml) show a spectral profile similar to water, with
FN10 having HU signal above water for all energy bins. The linearity plot is disorderly, with
the datapoints measuring HU across the concentrations for each energy not being consistent
with the linear polynomial fitted to the data. Another observation is the increased HU signal
for the ferric nitrate concentrations in energy bin 4 (49.8 - 80.0 keV). The k-edge of Fe = 7.11
keV, so an increased HU signal should be observed in the first energy bin (20.0 - 30.2keV),
with a gradual but continuous decrease in this signal across the other energy ranges. It is still
observed in the HA spectral plot the increase in attenuation within the second energy bin. This
should be expressed in the first energy bin to represent the calcium k-edge at 4.01 keV.
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(a) Linearity plot for FN samples in the ferric nitrate
phantom (small concentrations).





























(b) Spectral plot for FN samples in the ferric nitrate
phantom (small concentrations).
Figure 3.12: Linearity and spectral plot for the FN samples in the ferric nitrate phantom (small
concentrations).
100 200 400 600























(a) Linearity plot for the HA standards in the
ferric nitrate phantom (small concentrations).



























(b) Spectral plot for the HA standards in the ferric nitrate
phantom (small concentrations).
Figure 3.13: Linearity and spectral plot for the HA standards in the ferric nitrate phantom
(small concentrations).
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Material decomposition results
To establish the quantity of material within the ferric nitrate and hydroxyapatite samples,
measurements of the average quantity and its standard deviation were taken from a ROI for
each sample. The measurements were compared to the true material concentrations in the
following plots.
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Quantifying Ferric Nitrate signal from MD results using axial slice
R2 = 0.94705
(a) Plot quantifying the ferric nitrate signal from MD
results.
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Quantifying HA signal from MD results using axial slice
R2 = 0.99956
(b) Plot quantifying the hydroxyapatite signal from the
MD results.
Figure 3.14: Quantification of the (a) ferric nitrate and (b) hydroxyapatite signal from the MD
results. The diagonal line acts as a reference line to represent the linear trend the datapoints
should follow for accurate MD quantification.
The errorbars spanning each ferric nitrate concentration show large deviation from the mea-
sured quantified values. The small concentrations used indicate a large error associated with
MARS Visions’ capability to accurately calculate the correct quantification of each sample. The
quantification of the hydroxyapatite standards follows closely to the linear reference line for ac-
curate MD quantification, with small associated deviations. This is because the hydroxyapatite
standards are a factory manufactured product made specifically for calibration purposes.
Misidentification charts were produced to indicate what materials were being identified in
other material samples, and to determine the percentage of misidentification. In Figure 3.15a,
there is significant misidentification from HA, lipid and water across all ferric nitrate samples.
The highest ferric nitrate identification comes from FN4, however, this identification is only
∼ 50%. In contrast, the hydroxyapatite samples possess 100% correct identification across all
concentrations (Figure 3.15b). In comparison to the first ferric nitrate experiment in Section
3.3, four HA standards were used in this phantom, rather than three. This may have helped
the 100% HA identification, together with the lower FN concentrations not having a similar
spectral signal as the HA concentrations. The misidentification charts measure the signal from
each material within the material samples without any preset threshold on the minimum or
maximum concentration, unlike the MD image, which has a minimum threshold set for ferric
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nitrate and hydroxyapatite to eliminate any small concentrations which can be classified as
a misidentification. Therefore, the misidentification charts are showing the complete signal
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(b) Misidentification chart for the hydroxyapatite concentrations in the ferric nitrate phantom (small concentra-
tions).
Figure 3.15: Misidentification charts for (a) ferric nitrate and (b) hydroxyapatite concentrations
in the phantom.
3.4.4 Conclusion
There is no obvious misidentification between specific hydroxyapatite standards and the ferric
nitrate samples using the normal MARS MD (as seen in Figure 3.11), so the new methods were
not implemented in the analysis. Even so, the small ferric nitrate concentrations could not be
sufficiently identified with the MARS Vision material decomposition as containing ferric nitrate.
This is evident in the misidentification charts in Figure 3.15a, where the FN signal across all
ferric nitrate concentrations is <50%. On account of this, the large ferric nitrate concentrations
were reverted back to for further scans.
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3.5 Ferric Nitrate experiment (large concentrations with two
protocols)
3.5.1 Aim
The aim of this experiment was to investigate the material decomposition of a phantom con-
taining samples of ferric nitrate to represent iron, and standards of hydroxyapatite to represent
calcium. The large FN concentrations were employed again, based on the results of the small
concentrations in Section 3.4. This experiment was completed using two protocols: one which
is specifically used for plaque scans, and the other being the protocol implemented in the ferric
nitrate experiments. This was performed with the goal of combining the protocols by some
means for investigating intraplaque haemorrhage in future vulnerable plaque scans. The signif-
icance is that success with this work would allow development of a protocol for imaging plaque
samples for intraplaque haemorrhage.
3.5.2 Methods
Using both the FerricNitrate Protocol@80kVp and UOC Protocol Aluminium protocols, the
scans were run with their respective scan parameters. The phantom contained the ferric nitrate
concentrations 10mg/ml, 25mg/ml, 50mg/ml, 100mg/ml, 200mg/ml and 400mg/ml. The HA
concentrations used were HA100, HA200, HA400, and HA600. Also included were lipid and
water.
Figure 3.16: Ferric nitrate phantom using large FN concentrations.
In a previous unsuccessful scan replicating this experiment, the phantom instead contained
HA concentrations of HA50, HA100, HA200, and HA400. When the datasets were downloaded
and processed to run the MD, an error message appeared stating ‘Poorly formed basis vectors!’
This was because the angle of separation between two materials spectral profiles was too simi-
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lar, and hence the separation of the basis vectors between materials was too small for the MD
software to distinguish them. HA600 was not used in the phantom in this instance, which may
have given rise to the failure of the MD. HA600 has a high attenuation associated with it, and
in the energy images appears as a bright white signal. As a consequence of HA600 not being
present in the phantom, the energy images lacked this large attenuating concentrated material,
and thus showed little variation in the greyscale. This alone can give one reason to anticipate
difficulty separating the basis vectors and issues running the MD.
Initiating the MD was successful for the scan using the FerricNitrate Protocol@80kVp proto-
col, but the same error message was generated for the scan using the UOC Protocol Aluminium
protocol. Attempts to manipulate the data, by recalculating the attenuation coefficients and/or
ignoring a material concentration in the basis calculation did not resolve the issue, with the
basis vectors still not well defined for the system to distinguish materials. As a result, the
following results are only from the scan using the FerricNitrate Protocol@80kVp protocol.
3.5.3 Results and Analysis
The same image processing was completed as in previous experiments, and by setting LUT
thresholds for the materials the following optimised MD image was produced in MARS Vision.
Figure 3.17: Material decomposition of the ferric nitrate phantom on MARS Vision using large
FN concentrations. Ferric nitrate signal is red, hydroxyapatite is white, water is blue, and lipid
is yellow.
Energy image analysis
Linearity and spectral plots were produced for the ferric nitrate and hydroxyapatite concen-
trations from the FerricNitrate Protocol@80kVp protocol scan. Noteworthy is the similar
Hounsfield Unit signal in the spectral plots for the ferric nitrate samples FN200 and FN400, and
the hydroxyapatite samples HA100 and HA200. Consequently, there is evident misidentification
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in the optimised MD image between these samples, as seen in Figure 3.17. Both spectral plots
for FN and HA observe an increase in attenuation within the second energy bin, which does not
accord with the absorption edges of Fe and Ca that should occur within the first energy bin.
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(a) Linearity plot for FN samples in the ferric
nitrate phantom.
































(b) Spectral plot for FN samples in the ferric nitrate phan-
tom.
Figure 3.18: Linearity and spectral plot for the FN samples in the ferric nitrate phantom using
the large FN concentrations.
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(a) Linearity plot for HA samples in the ferric ni-
trate phantom.



























(b) Spectral plot for HA samples in the ferric nitrate phan-
tom.
Figure 3.19: Linearity and spectral plot for the HA samples in the ferric nitrate phantom using
the large FN concentrations.
Material decomposition results
Quantifying the ferric nitrate and hydroxyapatite signal measureable in MARS Vision revealed
concentration measurements that were significantly lower than the given (known) concentra-
tions. This is seen in the drop in the datapoint denoting the measured quantity, compared to
the reference line representing the slope of perfect quantification of the material concentrations
(Figure 3.20). When this analysis was carried out, this issue was noted and other datasets
were tested to evaluate their measured quantification of the samples. These too had notable
underestimations of the measured values. It was determined to be a calibration issue, with the
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MARS scanner undergoing tests to resolve the under reading of material concentrations.
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Quantifying Ferric Nitrate signal from MD results using axial slice
R2 = 0.99035
(a) Plot quantifying the ferric nitrate signal from MD
results.
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Quantifying HA signal from MD results using sagittal slice
R2 = 0.96183
(b) Plot quantifying the hydroxyapatite signal from
the MD results.
Figure 3.20: Quantification of the ferric nitrate (a) and hydroxyapatite (b) signal from the MD
results. The diagonal line acts as a reference line to represent the linear trend the datapoints
should follow for accurate MD quantification.
The hydroxyapatite signal has a considerable error associated with the datapoints in Figure
3.20b, which is unusual seeming the hydroxyapatite standards are factory manufactured specif-
ically for calibrations. This could be a result of the inaccuracy of MARS Vision in measuring
the material concentrations.
The following misidentification charts support the misclassification of ferric nitrate and
hydroxyapatite in FN200, FN400, HA100, and HA200, which is evident in Figure 3.17.
Figure 3.21: Misidentification charts for ferric nitrate in the FN phantom.
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Figure 3.22: Misidentification charts hydroxyapatite concentrations in the phantom.
New methods
The misidentification between ferric nitrate and hydroxyapatite in samples FN200, FN400,
HA100, and HA200 led to the implementation of new methods including the histogram method
and their corresponding ROC curves, percentage correct, and scatter plots with marginal his-
tograms.
Histogram method and ROC curves
The following histograms and ROC curves were produced using the coordinate information from
ROIs’ selected for the samples with misidentifications. The attenuation coefficients within the
ROIs’ were plotted in the following way for each energy bin to show the separation between the
samples and the trend of the attenuation across the energies.
The comparison of HA100 and FN400, and FN200 and HA200 shows almost perfect distinc-
tion between the materials, with an AUC value representing complete separation across most
energies. The separation between FN200 and HA100 is problematic, with the histograms con-
taining each materials attenuation coefficients bearing significant overlap across the energies.
This is especially apparent in the histogram for energy 4, which for FN200 and HA100 has a
corresponding AUC = 0.5982, thus providing an inadequate result for distinguishing these two
concentrations.
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Histogram for Energy 1 (HA100, FN400, HA200, and FN200 ROI)











































ROC Curves for Energy 1 with corresponding Area Under Curve (AUC)
AUC (HA100 and FN400) = 1.0000
AUC (FN200 and HA100) = 0.8089
AUC (FN200 and HA200) = 1.0000
AUC (FN400 and HA200) = 0.9658
Histogram for Energy 2 (HA100, FN400, HA200, and FN200 ROI)











































ROC Curves for Energy 2 with corresponding Area Under Curve (AUC)
AUC (HA100 and FN400) = 1.0000
AUC (FN200 and HA100) = 0.8604
AUC (FN200 and HA200) = 1.0000
AUC (FN400 and HA200) = 0.9880
Histogram for Energy 3 (HA100, FN400, HA200, and FN200 ROI)











































ROC Curves for Energy 3 with corresponding Area Under Curve (AUC)
AUC (HA100 and FN400) = 0.9999
AUC (FN200 and HA100) = 0.7704
AUC (FN200 and HA200) = 1.0000
AUC (FN400 and HA200) = 0.9540
Histogram for Energy 4 (HA100, FN400, HA200, and FN200 ROI)











































ROC Curves for Energy 4 with corresponding Area Under Curve (AUC)
AUC (HA100 and FN400) = 0.9988
AUC (FN200 and HA100) = 0.5982
AUC (FN200 and HA200) = 1.0000
AUC (FN400 and HA200) = 0.8027
Figure 3.23: Histogram plots comparing HA100, FN400, HA200, and FN200 across the four
energy bins. These are accompanied by ROC curves for each energy bin.
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Percentage Correct (PC)
For the four energy bins, the following PC values were calculated. These values directly relate
to the discrimination observed in the histograms and corresponding ROC curves. 2004 trials
were used to calculate the PC values, this being equivalent to the number of pixels within each
material ROI.
Percentage Correct E1 E2 E3 E4
HA100 and FN400 1.0000 1.0000 1.0000 0.9990
FN200 and HA100 0.7929 0.8503 0.7445 0.5664
FN200 and HA200 1.0000 1.0000 1.0000 1.0000
FN400 and HA200 0.9631 0.9860 0.9471 0.7944
Table 3.2: Calculated PC values for HA100, FN400, HA200, and FN200, for the four energy
bins.
Scatter plots with marginal histograms
Scatterplots were generated to visualize the relationship of the attenuation coefficients between
the energies. By comparing Energy bin 1 vs. Energy bin 2, Energy bin 2 vs. Energy bin 3, and
Energy bin 3 vs. Energy bin 4, a positive correlation was observed for the energies. Included
in these scatterplots are the marginal distributions of the energy bin on the x-axis and energy
bin on the y-axis as univariate histograms.
3.5.4 Conclusion
Only the FerricNitrate Protocol@80kVp protocol successfully completed the material decompo-
sition of the phantom. This still leaves the matter of whether the FerricNitrate Protocol@80kVp
and plaque UOC Protocol Aluminium protocol can be merged into a protocol that can have
optimised parameters for scanning plaque specimens for intraplaque haemorrhage. Although
the large ferric nitrate concentrations were implemented, there was significant misidentification
of ferric nitrate and hydroxyapatite signal in the samples FN200, FN400, HA100, and HA200.
Comparing these samples with one another, HA100 and FN400, and FN200 and HA200 showed
almost perfect distinction across the four energy bins. Further scans would need to be run
optimise this phantom.
54 CHAPTER 3. IRON VS. CALCIUM
0.2 0.25 0.3 0.35 0.4 0.45 0.5 0.55 0.6





























(a) Scatter plot comparing Energy 1 and Energy 2 attenuation coefficients.
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(b) Scatter plot comparing Energy 2 and Energy 3 attenuation coefficients.
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(c) Scatter plot comparing Energy 3 and Energy 4 attenuation coefficients.
Figure 3.24: Scatter plots with marginal histograms for E1 vs. E2, E2 vs. E3, and E3 vs. E4.
See an explanation on the previous page in section 3.5.3.
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3.6 FeCl and CaCl experiment
3.6.1 Aim
Following the results of the ferric nitrate phantom using large concentrations, a new experiment
was launched, with the aim of distinguishing iron and calcium using the ferric nitrate phantom
as a calibration phantom. To attempt to answer the questions surrounding material discernment
of iron and calcium, a mixed solution was produced to try to determine the point at which there
is enough iron in the voxel for the iron signal to predominate, and predominate over every other
signal. Also in question is whether the dominant iron signal is different to the same concentra-
tion of calcium in a separate voxel. The significance of this experiment is that, when more than
one material occupies part of a voxel, the material that is identified by the voxel will, in this
case, determine whether there is iron or calcium present. This is important for accurately de-
termining features of vulnerable plaque, such as intraplaque haemorrhage or microcalcifications.
3.6.2 Methods
A phantom was made up of three concentrations of FeCl (FeCl100, FeCl200, and FeCl400),
three concentrations of CaCl (CaCl100, CaCl200, and CaCl400), a 50/50 mixture of FeCl200
and CaCl200, lipid, and water. The chloride in the FeCl and CaCl samples should effectively
cancel out. The samples were made in moles, as 1g of Ca will have at least half the atoms of
1g of Fe. The scan was run using the FerricNitrate Protocol@80kVp protocol on the same day
as the ferric nitrate experiment in Section 3.5.
The concentrations used were 100, 200, and 400mM. In grams per ml that is:
• CaCl100: 14.7 mg/ml, CaCl200: 29.4 mg/ml, CaCl400: 58.8 mg/ml
• FeCl100: 23.05 mg/ml, FeCl200: 46.1mg/ml, FeCl400: 92.2 mg/ml
Figure 3.25: FeCl CaCl phantom.
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3.6.3 Results and Analysis
The following MD image was optimised by presetting the LUT thresholds for the iron, calcium,
and lipid channels. The minimum LUT thresholds were set as 0.1 for iron to represent a FN100
(100mg/ml) concentration, and 0.05 for calcium for HA50, with the maximum LUT threshold
set as the maximum signal for each material. The minimum threshold for lipid was set to 0.8,
with a maximum threshold at 1.0 to coincide with the fat density as approximately 0.9g/ml.
Figure 3.26: Optimised MD image of FeCl CaCl phantom. FN is shown as red, HA as white,
water as blue, and lipid as yellow.
The analysis of the FeCl and CaCl samples was done using the ferric nitrate phantom in
Section 3.5 as the calibration phantom. More suitable would be to use the three concentrations
of FeCl and CaCl as the calibration materials. This was trialled, by running the MD using
attenuation values from the FeCl and CaCl samples, however, the error stating ‘Poorly formed
basis vectors!’ lead to the MD not running. As a result, the analysis here is based on the ferric
nitrate phantom as the calibration phantom.
The following misidentification chart was produced. Most notable it the significant ferric
nitrate signal observed in the mixed FeCl200/CaCl200 solution. In the CaCl solutions there is
more misidentification from other materials such as water.
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Figure 3.27: Misidentification chart comparing the ferric nitrate and hydroxyapatite signal in
the FeCl, CaCl, and FeCl200/CaCl200 mixture solution.
By visualising the MD in MARS Vision, the quantity of ferric nitrate and hydroxyapatite
(mg/ml) could be measured in the samples. This was done using an axial, coronal, and sagittal
slice (only coronal slice data is shown in the following graph). FeCl100 and FeCl200 showed
close quantification to their concentrations in mg/ml, with FeCl400 (92.2mg/ml) having a FN
quantification of 146.24mg/ml in the MARS Vision MD. A significant undereading was observed
across the CaCl samples, remembering these are made up in mg/ml. In the FeCl200/CaCl200
mixture, the ferric nitrate signal measured at 168.43mg/ml, while the hydroxyapatite signal
measured at 9.39mg/ml.
Figure 3.28: Quantification of ferric nitrate and hydroxyapatite in FeCl, CaCl, and
FeCl200/CaCl200 mixture solution.
The reason behind the undereading of the samples is still unclear although testing of the
scanner was performed. Possible causes include phantom design and beam hardening effects.
Beam hardening is seen when an X-ray beam consisting of polychromatic energies passes through
an object. Low energy X-ray photons are preferentially absorbed, with the remaining high
energy photons not as easily attenuated. This leads to beam ‘hardening’. This is an issue
for high atomic number materials, which acquire increased attenuation at lower energies. The
58 CHAPTER 3. IRON VS. CALCIUM
design of the phantom and the placement of materials within the phantom may play a role in
the observed undereadings, as high atomic materials such as hydroxyapatite may affect the
attenuation coefficients measured from the ferric nitrate samples. Consequently, the ferric
nitrate calibration phantom will effect the quantification FeCl, CaCl, and FeCl200/CaCl200
in the material decomposition.
3.6.4 Conclusion
In an attempt to answer the questions surrounding material discernment of iron and calcium
the FeCl200/CaCl200 mixed solution showed a predominate iron signal over calcium, with a
measured quantity of 168.04mg/ml over the calcium signal at 9.39mg/ml. Future work can
further the progress of this experiment, by trialing different concentrations within the mixture
solution, to determine what concentrations of iron and calcium create the turning point at which
iron is distinguished over calcium. In this experiment, FeCl200 and CaCl200 were used in the
mixture. It may be possible to reduce the FeCl concentration in the mixture, while keeping
CaCl at 200mg/ml. This would be a practical next step to take. Continued investigations into
the undereadings in the material quantification measurements should be undertaken to solve
the issue for future scans.
3.7 Blood clots
3.7.1 Aim
Blood has various components, comprising erythrocytes, white blood cells, and platelets. These
occupy 45% of blood volume. Platelets role is to interact with clotting proteins to prevent
bleeding. Plasma is the liquid component of blood in which these components are suspended,
occupying ∼ 55% of blood volume. The aim of this experiment was to quantify how much ferric
nitrate signal would be contained within the prepared blood clots. There should only be a ferric
nitrate signal detected in the clots, as blood does not contain any calcium/hydroxyapatite.
3.7.2 Method
To conclude the ferric nitrate work, four blood clots were produced by my associate supervisor.
The vials containing the clots were carefully stabilised to the phantom holder and scanned with
parameters including a tube voltage of 80kVp, tube current of 55µA, 100ms exposure time and
2mm Al filtration. The protocol energy bins were preset at 20.0 - 30.2 keV, 30.2 - 40.1 keV,
40.1 - 49.8 keV, and 49.8 - 80.0 keV. This scan was run after the FeCl and CaCl experiment,
using the FerricNitrate Protocol@80kVp protocol which was implemented in the ferric nitrate
experiment in Section 3.5.
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Figure 3.29: Blood clot phantom images.
3.7.3 Results and Analysis
The following spectral plot compares the Hounsfield Unit signal of the four clots against the
ferric nitrate calibration phantom. As observed, the blood clots maintain an HU signal between
FN25 and FN50, with an increase in signal seen in the fourth energy bin, reaching HU values
between FN50 and FN100.




































Figure 3.30: Spectral plot for the blood clots against the ferric nitrate calibration concentrations.
Using the calibration phantom with the large ferric nitrate concentrations, the MD was run
for the blood clot scan. Visualising the result in MARS Vision, and setting the LUT minimum
thresholds to eliminate misidentifications, the following optimised image was produced. There
was HA signal observed in the MD image, however setting the HA LUT minimum threshold to
0.05 (equivalent to HA50) eliminated all HA signal in the image. This would be categorised as
misclassified HA, as no calcium-like signal should be expected in the blood clots.
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(a) Side on view of blood clot phantom with all mate-
rials present.
(b) Birdseye view of phantom, with FN, HA and energy
signal shown.
Figure 3.31: Optimised MD images of blood clots. FN is red, HA is white (no signal observed),
lipid is yellow, and water is blue.
Quantifying the amount of ferric nitrate within the blood clots was achieved in MARS
Vision by taking a ROI in an axial, coronal, and sagittal slice, and measuring the average signal
(mg/ml) and the standard deviation.
















Table 3.3: Quantity of ferric nitrate in the four blood clots measured in an axial, coronal, and
sagittal slice.
3.7.4 Conclusion
Using the calibration phantom with the large ferric nitrate concentrations, the MD was run for
the blood clot scan. A ferric nitrate signal was successfully observed throughout all four blood
clots, with no hydroxyapatite present.
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3.8 Summary
To summarise the key points of this chapter:
• Intraplaque haemorrhage is a common identifying feature of complex lesions leading to
acute ischaemic events, which arises from a disruption of thin-walled microvessels, resulting
in erythrocytes leaking into the plaque.
• Calcification regions in atherosclerotic plaques defend against plaque destabilisation, while
microcalcifications contribute to plaque instability by promoting stress accumulation within
the ECM.
• There is a strong relationship between intraplaque haemorrhage and lipid, with intraplaque
haemorrhage contributing to local lipid deposition, acting as a source for proinflamma-
tory responses. The cholesterol content in erythrocytes could be an indicator of plaque
progression to vulnerability.
• Misidentification was observed between samples of ferric nitrate and hydroxyapatite in
the material decomposition. By implementing new methods, the energy information from
the samples enabled separation of the material concentrations.
• The large ferric nitrate concentrations were more reliable at accurately identifying the
presence of ferric nitrate. Although the small ferric nitrate concentrations more closely
represent concentrations of iron found in the human body, significant misidentification
was seen throughout the samples.
• The iron signal in the FeCl200/CaCl200 mixed solution predominated. Substantial under-
eadings of material quantifications were recorded, which may be a consequence of phantom




This chapter introduces the technique of PCA, and its ability to evaluate spectral information
in a dataset. The aim of using PCA is to analyse the ferric nitrate phantom datasets, and see
whether PCA can be effectively implemented as a new method for distinguishing materials of
similar spectral profiles such as iron and calcium. Significant advantages of using PCA include
it not requiring prior knowledge of the materials being imaged, and that it can be applied to
large datasets.
An introduction into PCA is given in section 4.2, with the methodology of how PCA was
achieved on the datasets and the results detailed in sections 4.3 and 4.4, respectively. Section
4.5 gives conclusions to the use and effectiveness of PCA, and a chapter summary is described
in section 4.6.
4.2 Principal Component Analysis (PCA)
What is PCA?
Principal Component Analysis (PCA) is a technique often used to make data easier to visualise
and interpret. It is a mathematical algorithm that reduces the dimensionality of the data,
while retaining most of the variation in the dataset [47] and reducing noise. The technique
is very universal, as it can be applied to image data of any dimensionality, and requires no
prior knowledge of the materials being analysed in the dataset (how the spectral information
varies within the data) [48]. PCA is able to reduce the data dimensionality be identifying
directions, called principal components, along which the variation in the dataset is maximal.
The direction of the first principal component is along the path of the dataset that shows
the largest variation and highest contrast. The second principal component is the direction
uncorrelated to the first component along which the data shows the largest variation [49].
Remaining principal components continue in this manner until all data is represented [50].
Although the first principal component is generally viewed as containing most of the information
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in the system, with the last principal components regarded as noise, principal components with
small variances will elevate the subtle contrast between two very similar materials [51]. Along
these directional axes in the new coordinate system, the dataset variances are uncorrelated - in
other words, if two materials in a dataset have similar absorption spectra that are only slightly
distinguishable, the PCA algorithm will emphasise the contrast between the two materials [52].
As a result, strong patterns in the data are accentuated, with the processed images having
enhanced contrast and improved signal-to-noise ratio compared to the datasets original images.
PCA behind the scenes: The application of PCA to multi-energy data
The intent of PCA is to identify linearly independent patterns of variance within datasets,
creating an image that has maximal contrast between materials. The following mathematical
notations demonstrate this concept.
Let x represent K different energies. The aim is to find linear transformations αTi x that
possesses maximum variance in contrast between materials [53]. αT is the transpose of α, with






where αij are constants and xj are elements of x. In the PCA solution the intensity value of
each pixel is thus a weighted sum of the intensity values for corresponding pixels in the images
for the multiple energies [52]. Lagrange multipliers are applied in the derivation of the PCA
method, which maximise the variance of the dataset. This results in the following equation,
|Σx − λIK |αi = 0 (4.2)
where Σx is a covariance matrix that describes the spread of intensity values across the vector
space of x, λ represents the eigenvalue of Σx, and λIK is a (K × K) identity matrix.
To carry out PCA, the following is performed for each voxel: Firstly, the covariance matrix
is calculated. Σx is defined by






(xi −m)(xi −m)T (4.4)
where E is the expectation operator and m is the mean of x.
Following this, the characteristic equation for the eigenvalues λ is solved. The eigenvalues
are then sorted in order of decreasing value.
Σx − λI = 0 (4.5)
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With the sorted eigenvalues, the PCA images for each principal component of interest are
generated. The eigenvectors of the algorithm detail the remapping of the brightness values of
each pixel, with the eigenvectors filling the αij terms in equation 4.1. Each pixel is given a new
brightness value by a weighted sum of the corresponding pixels in each of the spectral bands
[52].
4.3 Method
PCA was completed using Matlab functions created by a past MARS PhD student. The main
code reads in four .tif files (one for each energy bin) as a 480×480 single, then converts the
four images to a double. The four .tif files used were from one slice chosen from each energy,
which is not optimal for analysis. A new Matlab script was created, which loaded all .tif files
from a scan as a stack in the Workstation. This was done for the four energies, resulting in four
stacked folders for E1, E2, E3, and E4.
Next, the code prompts the user to input a start slice and a finish slice from which to
analyse the .tif files within each stack. The number of files selected are calculated by taking
the difference between the start and finish slices. From the start slice indicated, the number of
files chosen, say 10, are taken and stored in a separate stack. These 10 .tif files are averaged
by taking the mean, resulting in a single .tif file representing the averaged image over the 10
slices chosen between the start and finish slices. This was completed for the four energy folders.
At this point, the averaged .tif files were converted to Hounsfield Units using the Hounsfield
Unit equation, in order to increase the signal from the attenuation coefficients.
Using the new averaged .tif files in the main PCA code, the code specified the number of
images as four (relating to the number of energy bins), and prompted the user for the number
of materials. Air is included as a material, otherwise it is assigned to other materials. Through
a for loop, a region of interest (ROI) was selected by the user for each material. This was
generated by the inbuilt Matlab function roipoly. In a phantom with multiple concentrations
of one material, only one material concentration can be selected to represent that material with
the ROI. The code implemented two functions. The first function takes the matrix containing
the ROI information and transforms into eigenspace. This is done by computing the singular-
value decomposition (SVD)/PCA of the input matrix. Outputs of this function include the
transformation matrix and transformed input. The second function measures the Euclidean
distance in eigenspace. The PCA code generates binary images for the material channels, and
maps the HU from each energy bin image onto the material bins, creating the PCA images of
each material.
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4.4 Results and Analysis
PCA was completed on the ferric nitrate phantoms using the large and small concentrations.
This was implemented as one of the new methods to try and distinguish iron and calcium. The
PCA code was run multiple times, performing trial and error with different material concentra-
tions for the chosen ROI.
The following results are two best outcomes for the ferric nitrate phantom (large concentra-
tions). The two outcomes that showed the most correct material identification used material
concentrations HA600, FN50, and I9, and HA600, FN100, and I9.










































































































































































































































































































(b) PCA for ferric nitrate phantom (HA600, FN50, I9).
Figure 4.1: PCA for ferric nitrate phantom (large concentrations) using HA600, FN50, and I9
as the material ROI.
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The hydroxyapatite channel recognised HA400 and HA600, while HA100 was identified in
the iodine channel, along with FN400. Due to iodine’s strong greyscale signal, PCA perceived
the HU signal of HA100 and FN400 to more closely resemble the greyscale for I9 and I18 in the
iodine channel. The k-edge of iodine is observed in E3 with an increased HU signal in the iodine
channel. The ferric nitrate concentrations were correctly observed in the ferric nitrate channel,
except for FN400. Lipid, water, and air did not have a significant HU signal, and hence their
PCA images have a colour representing a signal at 0 HU, as seen on the colour scale alongside
each PCA image. The following is the PCA results for HA600, FN100, and I9.











































































































































































































































































































(b) PCA for ferric nitrate phantom (HA600, FN100, I9).
Figure 4.2: PCA for ferric nitrate phantom (large concentrations) using HA600, FN100, and I9
as the material ROI.
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The hydroxyapatite channel recognised HA400 and HA600, while HA100 was identified in
the ferric nitrate channel. Across the energies in the iodine channel, I9 and I18 were clearly
identified, along with FN400 and speckled regions of HA100. In the water channel there are
speckled regions of FN25 detected. As in Figure 4.1, lipid, water, and air have a small HU
signal, resulting in 0 HU across the energies.
The following PCA result is the best outcome using the ferric nitrate phantom with small
FN concentrations. The best material concentration combination was HA100 and FN10 as the
material ROI.


















































































































































































































































































(b) PCA for ferric nitrate phantom (HA100, FN10).
Figure 4.3: PCA for ferric nitrate phantom (small concentrations) using HA100 and FN10 as
the material ROI.
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The hydroxyapatite concentrations have such a dissimilar HU signal compared to the small
ferric nitrate concentrations, causing all the HA concentrations to be correctly identified in the
HA channel. In the ferric nitrate channel, only FN10 shows some speckled signal across the
energies. Due to the low HU signal for the lower concentrations of ferric nitrate, and of lipid,
water, and air, the rest of the PCA images observe a signal of 0 HU.
An improvement that should be considered for future use of PCA is incorporating more
than one material concentration into the ROI selection. In this analysis, one concentration
of each material was chosen in any given run of the PCA code. Trial and error was used to
determine what material concentration combinations gave the most accurate outcome of ma-
terial identification. By creating some additional Matlab code that could take on more than
one concentration, and use this ROI information in a way to create a basis for each material, a
more accurate PCA outcome may result.
Currently, the PCA outcomes depend entirely on the material concentration combination
chosen. For the ferric nitrate phantom using large FN concentrations, if FN400 was chosen to
represent the ferric nitrate channel, any material that showed a similar HU/greyscale signal to
FN400, such as HA400 and HA600, were misidentified as ferric nitrate. If a low HA concen-
tration was chosen, say HA100, any HU/greyscale signal above HA100 may fall into a different
channel, such as HA400 and HA600 identifying in the iodine channel. This was due to iodine’s
strong HU signal. An attempt was made to produce some Matlab code to improve the outcome
of PCA, but was not completed in the timeframe of this thesis.
4.5 Conclusion
PCA performs moderately for analysing HU/greyscale and its ability to distinguish materi-
als. For the ferric nitrate phantom with large FN concentrations, two optimal outcomes were
presented, although there were still some material concentration misclassifications. The ferric
nitrate phantom with small FN concentrations had strong identification of all four hydroxya-
patite concentrations. FN10, the highest ferric nitrate concentration in the phantom, was the
only FN sample to show any signal in the ferric nitrate channel. This was due to the other FN
samples having too smaller concentration.
Comparing PCA to the MD results for the ferric nitrate phantoms, accurate HU quantifica-
tion is recorded with PCA. Looking at Figure 3.4b and Figure 3.5b, the ferric nitrate phantom
spectral plots (large concentrations), the Hounsfield Units recorded match the HU displayed in
the FN and HA channel of the PCA chart in Figure 4.1b and Figure 4.2b. This is also repre-
sented in the ferric nitrate phantom using small FN concentrations. It was noted in the PCA
chart that only FN10 showed any FN signal in the FN channel (Figure 4.3b). This is supported
by the spectral plot (Figure 3.12b) in the Iron vs. Calcium chapter, where FN10 is the only
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ferric nitrate sample to have positive HU across all energies. The other ferric nitrate samples
were too low in concentration for an accurate HU reading, hence they have shown no signal in
PCA. The four HA standards in the phantom show accurate HU measurements in energy image
analysis and with PCA.
Although PCA is not a perfect technique and does not yet possess 100% correct identification
of all materials, it is a worthwhile technique to understand and develop. The phantom used
would need to be optimised and trialled, to see how the PCA code behaves with different material
concentrations. By extending the code to hold more than one concentration per material, the
ability of PCA to distinguish materials could be improved.
4.6 Summary
• PCA is a mathematical algorithm that uses a linear transformation to rotate the data into
a new coordinate system. This reduces the dimensionality of the data while maximising
the variances of the dataset.
• It is a very applicable technique, which can make features in the original data visible
that were previously not discernible. PCA requires no prior knowledge of the materials
being analysed in the dataset, with resultant images often having improved contrast and
signal-to-noise ratio.
• PCA was performed on two phantoms, the ferric nitrate phantom with large FN concentra-
tions, and the ferric nitrate phantom using small FN concentrations. The best outcomes
from PCA were presented. For the ferric nitrate phantom (large concentrations), the best
material concentration combinations were HA600, FN50, and I9, and HA600, FN100, and
I9. The ferric nitrate phantom (small concentrations) had the best material identification
using the samples HA100 and FN10.
• Comparing PCA to MD results, accurate Hounsfield Units were recorded between the
spectral plots of the ferric nitrate phantoms and PCA.
• PCA correctly identified some materials, with the odd misclassification. Further improve-
ments to the PCA code to incorporate more than one material concentration into the ROI
selection could improve the ability of PCA to distinguish materials.
• PCA was included in the 1st version of MARS Vision for material decomposition, but
has since been removed. Although PCA does not yet possess 100% correct identification
of all materials, PCA should be implemented into MARS Vision again alongside current
material decomposition techniques. With further improvements, PCA would provide team
members with an additional method to compare results with MD analysis.
Chapter 5
Plaque and ApoE mice studies
5.1 Overview
This chapter displays the results of multiple atherosclerotic plaque scans and apoE-deficient
mouse scans. The significance of scanning carotid plaque specimens relates to the identification
of calcifications for interpreting plaque stability, and visualising necrotic lipid cores, which are
a known feature of vulnerability. Studying atheromas is linked with the apoE mouse model,
which is well established for human atherosclerosis research.
Section 5.2 looks into atheroma research, showing the capability of the MARS spectral
scanner for plaque scanning and material decomposition. Section 5.3 describes the use of apoE-
deficient mice on atherosclerosis research, displaying MD results from scans performed on apoE
mice. A summary of this chapter is given in Section 5.4.
5.2 Atherosclerotic plaques
5.2.1 Atheroma research
The identification of vulnerable atherosclerotic plaque features in spectral CT has increased the
amount of information that can be visualised and interpreted. To verify what has been identi-
fied in CT images, histology is a useful technique for studying the microscopic composition of
tissues in an atheroma. Histological classification of plaques is often used to denote a plaques
progression and stabilisation.
The atherosclerotic plaques studied here are from the carotid artery. These are surgically ex-
cised after the patient has suffered a stroke. Most strokes are associated with carotid bifurcation
disease, with the majority thromboembolic in origin. The carotid bifurcation is the intersection
between the common carotid and the internal and external carotid arteries, which supply blood
to the brain, and the face and scalp, respectively. The formation of a clot (thrombus) in a blood
vessel breaks loose and travels in the blood stream to plug another vessel, causing a blockage
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in the carotid artery and a subsequent stroke.
Histological examination of plaque specimens is achieved through lipid staining, which high-
lights lipid structures in biological tissues for microscopic viewing. The technique of lipid
staining has become a valuable tool in detecting and differentiating components of lipid within
tissues. Cholesterol is the major lipid variety in atherosclerotic lesions and accumulates in un-
esterified and esterified forms [54]. Neutral lipids are hydrophobic molecules that lack charged
groups and act as storage lipids for cells. They include glyceryl lipids such as triacylglycerols
and cholesterol esters. When there are excess nutrients present in the cells the storage lipids
accumulate, and when the amount of neutral lipids incorporated into biomembranes reaches
capacity, they are sequestered from the cytosolic environment in the form of lipid droplets [55].
Upon requirement, the storage lipids are mobilized by triacylglycerol lipases and steryl ester
hydrolases.
Studies into lipid deposition in atherosclerosis have highlighted cholesterol’s role in plaque
progression. Rapp et al. established that an increased percentage of free cholesterol (in relation
to total cholesterol) was associated with evolution of the atherosclerotic process [56]. It was
demonstrated by Klemp et al. that lesion cores exhibited an increase in the percentage of free
cholesterol, whereas lesion caps had an enrichment of cholesteryl esters [57]. These studies give
momentum to the technique of lipid staining, and for uncovering what progressive role lipid
deposition plays in atherosclerosis.
There are a handful of dyes used for lipid staining. The lipid-soluble dye oil-red O only
stains neutral (hydrophobic) lipids such as esterified cholesterol and triglyceride, because their
solubility in liquid deposits in these lipids [58]. Oil-red O staining has been implemented along-
side fluorescent-labeled oxLDL uptake to optimize the method for assessing foam cell formation
through the intracellular lipid accumulation of macrophages [59]. It has been shown that most
plaques, particularly advanced lesions, contain lots of non-neutral lipids such as unesterified
(free) cholesterol and cholesterol crystals, so oil-red O would not stain significant portions of
the lipids present.
In contrast, the fluorescent probe filipin stains non-neutral lipids, specifically binding to
3-B-hydroxysterols [60]. One study looking into the localization of unesterified cholesterol in
human atherosclerotic plaques suggested that unesterified cholesterol could be associated with
calcium-containing deposits [61]. The use of filipin and oil-red O simultaneously allows for
differentiation between unesterified and esterified cholesterol, respectively, with generally no
overlap in accumulation in the same cells or in the same extracellular loci [58].
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Nile red is a dye that stains both neutral and non-neutral lipids. It acts as a fluorescent
hydrophobic probe, as it is only strongly fluorescent in the presence of a hydrophobic environ-
ment. The dye is very soluble in the lipids it is intended to show, and does not interact with
any tissue constituent except by solution [62]. An additional feature of Nile red is its ability to
stain in slightly different colours. When it is dissolved in neutral lipids such as triacylglycerol
and cholesterol ester droplets, Nile red fluoresces yellow-gold. However, when Nile red dissolves
in more polar solvents or phospholipids, the dye fluoresces red [63]. The ability of Nile red to
stain neutral and non-neutral lipids with varied colouring may be advantageous over oil-red O
and filipin for assessing lipid deposition in atherosclerotic lesions.
Throughout the timeframe of this thesis, carotid plaque specimens donated by patients from
Christchurch hospital were collected and stored to await scanning. The aim of scanning these
plaques was to see how well the scanner could determine calcifications, among regions of lipid
and the tissue/water signal. Ideally, lipid staining would have been performed to verify the
composition of the plaques, however the timeframe of the thesis could not accommodate this.
5.2.2 Method
Plaque specimens were collected from surgery and immediately stored in an -80 or -20 freezer,
depending on the time at which the plaques intended to be scanned. The plaques were defrosted
for the scan. A HA calibration phantom containing concentrations of hydroxyapatite, lipid, and
water was scanned before (or after) the plaque scan, but more importantly on the same day, to
ensure an accurate material decomposition. The plaques were then individually positioned into
a PCR tube and secured to the phantom holder. For the HA calibration scan and the plaque
scans, the UOC Protocol Aluminium protocol was used, with a tube voltage of 118kVp, tube
current at 23µA, exposure time of 100ms, and a 2mm Al filtration. The four energy bins used
were in the range 30.0 - 39.9 keV, 39.9 - 50.0 keV, 50.0 - 60.0 keV, and 60.0 - 118.0 keV.
Figure 5.1: Picture of a carotid plaque specimen in the MARS Spectral scanner.
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5.2.3 MD plaque images
The following plaques were scanned in one day with the HA calibration phantom. The plaques
were cut longitudinally through the bifurcation and photographed by a UC Biological Sciences
PhD student. The midsections of each plaque are positioned alongside their MD image. The
results suggest a partial volume effect from the lipid channel. There is no strong lipid signal
within the plaque to represent a lipid core, these suspected areas identifying as a water/tissue
equivalent. Lipid is only observed around the surface of the plaque, which is seen as a partial
volume effect. We expect to see a necrotic lipid core in some of these plaques.
Interpreting these results in regards to calcium, lipid, and iron content, these are culprit
lesions in patients that have recently had a stroke, and hence the rupture has begun to heal
before endarterectomy surgery has excised the plaque. As a result, some lipid core has poten-
tially spilled out, and a blood clot in the repair phase indicates the presence of concentrated
iron in the plaque region. Microcalcifications are common in plaques, and may be detectable in
the MARS scanner through sub-voxel sized HA deposits giving a calcium signal spectrally for
the voxel. There may be more calcium and iron present in the carotid plaque specimens rather
than lipid, which may have escaped in the rupture, hence the importance of creating a phantom
capable of measuring iron in plaque specimens.
In regards to the scanning of the plaques, the ability to identify lipid may be a result of the
protocol used. The Al protocol may identify more voxels as calcium (with no set thresholds), and
hence the MD cannot give an accurate lipid content. If the Al protocol is much more sensitive
to calcium, a future experiment would be to scan the same plaque specimens with the brass
protocol, which may give significantly less calcified voxels and measurable lipid content. The use
of a brass filter in a brass protocol should provide more reliable microcalcification assessment.
Notable also is the update in camera from a one-chip camera to a three-chip camera partway
through the year. This may have played a role in the plaque scanning, with the detection of lipid
when calcium is present in the phantom. Relating to the phantom work throughout this thesis,
an aluminium filter protocol was used. For plaque scanning, the Al protocol was recommended
as it was used for all phantom experiments, and its ability to image plaque specimens in previous
theses makes it an established protocol. Further experiments to determine why the lipid signal
is not represented correctly are needed, with histology being performed on plaque specimens to
confirm the composition. Another experiment involving plaque specimens and the ferric nitrate
phantom work includes using the ferric nitrate samples as the calibration phantom, in order to
investigate possible intraplaque haemorrhage within the specimens. The phantom and protocol
need continued work to be optimised.
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(a) Plaque 82 LHS. (b) Plaque 82 photograph. (c) Plaque 82 RHS.
(d) Plaque 94 LHS. (e) Plaque 94 photograph. (f) Plaque 94 RHS.
(g) Plaque 115 LHS. (h) Plaque 115 photograph. (i) Plaque 115 RHS.
(j) Plaque 118
LHS.










Figure 5.2: Plaques 82, 94, 115, 118, and 136 photographs and MD results.
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5.3 Apolipoprotein E-deficient mouse model
5.3.1 ApoE mouse model
To model atherosclerosis in research, the apolipoprotein E-deficient (apoE-/-) mouse was cre-
ated for the purpose of studying atherosclerotic lesions resembling those observed in humans.
The purpose for using this mouse model relates to the long term goal of visualising atheroscle-
rosis in humans. By being able to see atheroma progression in apoE mice, the next step is to
see this in live mice using the MARS scanner, progressing towards scanning patients susceptible
to atherosclerosis. Apolipoprotein E is a glycoprotein synthesised mainly in the liver and brain,
and is a component of all lipoproteins except low-density lipoproteins [64]. ApoE functions as a
ligand for lipoprotein receptors, mediating the clearance of chylomicrons and very low-density
lipoprotein remnants. ApoE is also synthesised by monocytes and macrophages in vessels,
and is suggested to have local effects on cholesterol homeostasis and inflammatory reactions in
atherosclerotic vessels [65]. Therefore, quality MARS images of apoE mice will enable features
of atherosclerotic lesions to be interpreted and quantified within aortic vessels.
A knockout mouse is a genetically modified mouse that has an existing gene inactivated, or
’knocked out’, which is replaced/disrupted with an artificial piece of DNA. In the apoE model,
the gene coding for the apoE protein is inactivated by gene targeting to disrupt the apoE gene
in embryonic stem cells [66]. Specifically, the creation of knockout mice involves the insertion of
the neomycin resistance gene by homologous recombination in place of exon 3 and part of intron
3 of the apoE gene [67][68]. The lack of apoE protein in their plasma impair the clearance of
lipoproteins, leading to the development of hypercholesterolaemia and spontaneous atheroscle-
rosis.
ApoE knockout mice are an established model in atherosclerosis research. This rodent
model resembles humans metabolically and pathophysiologically; its size allows metabolic and
physiological studies, with mice developing end-stage lesions comparable with that in humans
[67]. These atherosclerotic lesions are aggravated when mice are fed a high-cholesterol, Western-
type diet [69]. Studies have demonstrated that apoE mice develop a full range of lesions, from
fatty streaks to fibrous plaques. Nakashima et al noted that lesion development in mice fed a
chow and a Western-type diet was not only seen in the aortic root but throughout the aorta
and its principal branches [70]. This lesion development throughout the arterial tree was not
observed in control mice. A common feature of atherosclerosis is an increase in the stiffness of
the arterial wall, leading to decreased vascular elasticity and compliance. Research groups [71]
[72] measuring vascular stiffness though pulse-wave velocity (which increases with increasing
stiffness) indicated that apoE knockout mice have increased cardiac output and stroke volume,
along with decreased peripheral vascular resistance. The elevated cardiac output could be a
result of coronary atherosclerosis and endothelial dysfunction, limiting blood supply to the
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heart, forcing the heart to work harder.
5.3.2 Mouse scans
Throughout the timeframe of this thesis, a handful of apoE mice scans were performed. The
following scan used a 12 month old male apoE mouse weighing 32g, with the goal of visualising
lipid signal in the liver and potential arteries, and looking for calcifications. The calibration
phantom for all mice scans contained concentrations of hydroxyapatite, lipid, and water. The
Al Protocol UOC protocol was implemented, with scan parameters including a tube voltage of
118kVp, tube current 17µA, exposure time of 220ms, and 2mm Al filtration. The four energy
bins were set at 18.0 - 29.9 keV, 29.9 - 44.9 keV, 44.9 - 77.9 keV, and 77.9 - 118.0 keV.
(a) MD image showing energy and water signal. (b) MD image showing energy, lipid and water signal.
(c) MD image showing energy, HA, lipid, and water
signal.
Figure 5.3: MD images of 12 month old male apoE mouse. The hydroxyapatite signal is white,
lipid is yellow, and water/tissue is blue.
The material decomposition showed lipid signal around the body, with a dense signal ob-
served in the area about the liver. This suggests the mouse may have had a fatty liver due
to its inability to clear lipoproteins sufficiently. While dissecting the mouse after scanning,
the liver had areas of a lighter colouring rather than the deep red the liver is normally. This
supports the observation of fat deposition within the liver. No calcifications or lipid relating to
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atherosclerosis were detected. This is due to the image resolution and accurately deciphering
the area in the whole mouse scan where calcifications and lipid cores are expected. The ability
to accurately identify calcifications and lipid in the liver and aorta in the whole mouse scan was
quite tricky. In the next apoE mouse scan, the aorta and liver would be dissected and scanned
separately, to see it that would help visualise features of atherosclerosis.
Figure 5.4: Longitudinal view of apoE mouse scan. Dense lipid signal (yellow) seen in the area
where the liver may be located.
5.3.3 Aorta and liver scan
In this experiment an old apoE mouse was scanned and dissected to remove the aorta and
liver to be scanned separately. The motivation behind this was to scan the organs where
calcifications and lipid were expected. By doing this outside the body, a clearer view can be
achieved, without the obstruction of the mouse body reducing the visualisation of these organs.
The UOC Protocol Aluminium protocol was implemented, with scan parameters including a
tube voltage of 118kVp, tube current 23µA, exposure time of 100ms, and 2mm Al filtration.
The four energy bins were set at 30.0 - 39.9 keV, 39.9 - 50.0 keV, 50.0 - 60.0 keV, and 60.0 -
118.0 keV.
Figure 5.5: Picture of apoE mouse aorta and liver in PCR tube for scanning.
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(a) MD image showing HA signal. (b) MD image showing HA and water signal.
(c) MD image showing HA, lipid, and water signal.
Figure 5.6: MD images of the aorta and liver of an old apoE mouse. HA is represented in white,
lipid in yellow, and water/tissue in orange.
The HA signal was set to 0.05 in the MD, to represent HA50. Possible microcalcifications
in the liver are observed in Figure 5.6a. Most notable is the large calcified region at the
intersection of the descending aorta and the heart. This is a very strong signal of a suggested
calcified plaque. Lipid signal tended to show around the surface of the aorta and liver, this
being a result of the partial volume effect. By dissecting the aorta and liver and scanning
separately, areas of calcification and lipid deposition can be visualised, which may not have
been identifiable in the whole mouse scan. These MD images of the whole mouse scan (Figure
5.3) and the apoE mouse aorta and liver (Figure 5.6) have not used any contrast agent to help
with the visualisation; the images are a result of the calibration phantom and optimising the
MD images based on the density of the materials and the HA misidentification chart.
5.4 Summary
• Lipid staining is a useful tool in histological examination, highlighting lipid structures in
atherosclerotic plaques for microscopic viewing.
• The lipid-soluble dye oil-red O only stains neutral (hydrophobic) lipids such as esterified
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cholesterol and triglyceride, because their solubility in liquid deposits in these lipids. The
fluorescent probe filipin stains non-neutral lipids, specifically binding to 3-B-hydroxysterols.
Nile red is a dye that stains both neutral and non-neutral lipids. It acts as a fluorescent
hydrophobic probe, as it is only strongly fluorescent in the presence of a hydrophobic
environment.
• Carotid plaque specimens were scanned with the MARS Spectral scanner, identifying
regions of calcifications. Little lipid signal was observed in suspected necrotic core regions.
Further experiments are needed to determine the reason for this.
• In the apoE mouse model, the gene coding for the apoE protein is inactivated by gene
targeting to disrupt the apoE gene in embryonic stem cells. A 12 month old male apoE
mouse was scanned to investigate the hydroxyapatite and lipid signal. An apoE mouse
aorta and liver were dissected and scanned separately. A large calcified region was located
at the intersection of the descending aorta and the aorta. This was measured as equivalent
to HA80 by setting the HA signal to 0.08 to eliminate the calcifications in the liver using
the MARS Vision software.
• The apoE mouse and aorta/liver scan show the value of the MARS spectral scanner, as
these images have not used any contrast agent to aid the visualisation. The optimised
images are based solely on the calibration phantom and material decomposition.
Chapter 6
Conclusion
The objective of this research was to perform quantitative imaging of vulnerable atherosclerotic
plaques using the MARS spectral scanner. Each of the main components in atherosclerosis were
investigated, including lipid, iron, and calcium. Lipid, iron, calcium and water-like components
of plaque have distinguishable energy responses according to their spectral profiles, making them
visible in the material decomposition. The concept of spectral CT was described, with details
of how the scanner uses Medipix x-ray detectors to attain multiple-energy attenuation data.
The value of the MARS spectral scanner in molecular imaging was discussed, with benefits in
depicting markers of disease activity and disease burden, especially in the role of identifying
and directing treatment for vulnerable atherosclerotic plaque.
Lipid experiments involving LDLs were established by joining iodine to the LDL. With accu-
mulated LDL in lipid regions of atheromas, successfully joining a high Z material would enable
lipid, a low-contrast material, to be visualised using spectral CT. The first experiment observed
that at 10 mg/ml LDL, there was no measurable iodine signal in the liquid LDL samples in
its native (control) or iodinated form. In the precipitated LDL however, both the native and
iodinated samples revealed a significant iodine signal not only in the pellet but also throughout
the 50% water 50% TCA solution the pellets were held in. The chlorine atoms in the TCA
were recognised as an iodine signal in the material decomposition, which led to future pellet
experiments being held in air in the PCR tubes. The following experiment effectively joined
gold and iodine to 10 mg/ml precipitated LDL, with the material decomposition measuring a
gold signal in the Au-LDL pellet in the range 13-14 mg/ml across axial, coronal, and sagittal
slices. Iodine measurements produced a signal in the I-LDL pellet in the range 65-74 mg/ml
across axial, coronal, and sagittal slices. The native n-LDL pellet produced no gold or iodine
signal as anticipated, displaying as water in the MD. This optimised method was adapted to
U937 cells, however the insufficient amount of LDL added to the cells (maximum concentration
at 2 mg/ml) led to no gold or iodine contrast detected in the cell samples. The most suitable
next step would be to repeat the experiment using ox-LDL rather than native-LDL, which may
increase the uptake by the cells.
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Ferric nitrate experiments were performed to optimise phantom studies for distinguishing
iron and calcium. By principle of iron and calcium’s similar spectral profiles, MARS MD showed
misidentifications between particular ferric nitrate and hydroxyapatite material concentrations.
Using the energy information from these misidentified materials, the material concentrations
could be distinguished. This clearly demonstrates the superior ability of spectral CT technology
over conventional CT in separating materials relevant in atherosclerosis. Initially using large
ferric nitrate concentrations, small concentrations were studied, which more closely represented
concentrations of iron in the body. Although there was no obvious misidentification, the small
ferric nitrate concentrations were too small for the MARS system to accurately identify them
as containing ferric nitrate using the MARS Vision material decomposition. Throughout the
ferric nitrate experiments, an attempt was made to scan the ferric nitrate phantoms using two
scanning protocols: the protocol currently used for ferric nitrate scanning, and the protocol
used for plaque scanning. This undertaking was unsuccessful, due to errors when initiating the
MD to run for the plaque protocol. With the long term goal of scanning atherosclerotic plaques
to visualise intraplaque haemorrhage, an optimised phantom and scanning protocol is essential.
Further work is necessary to develop an optimised phantom and protocol based on these find-
ings, in order to make intraplaque haemorrhage and calcification visualisation attainable at the
clinical level using MARS spectral CT.
This thesis also demonstrates the MARS spectral scanners ability to identify components of
atherosclerotic plaque by investigating excised plaque specimens from patients and plaque de-
velopment in mouse models. In the plaque study, large calcifications were observed around the
bifurcation region of the artery. There were no obvious lipid signals attributing to a necrotic
lipid core in the plaques. The ability to identify lipid may be a result of the protocol used.
The Al protocol may identify more voxels as calcium (with no set thresholds), and hence the
MD cannot give an accurate lipid content. Areas of further investigation include scanning with
a different protocol, which may be less sensitive to the calcium channel. ApoE mice showed
possible lipid deposition in the area of the body suspected to be the liver. By excising the apoE
mouse aorta and liver, and scanning separately after the whole mouse scan, visualisation of
calcifications was significantly more identifiable. The ability to identify regions of calcifications
and lipid depositions around the bifurcation region in excised apoE mouse organs is promising,
but more important is the ability to identify these materials in a whole mouse scan. Challenges
of this include areas of the mouse body obstructing the view of specific regions of the aorta and
arteries, reduced resolution and image contrast. The use of injectable contrast agents such as
gold nanoparticles will be a future step in visualising atherosclerosis with the apoE mouse model.
The work in this thesis has established many avenues for future work. In regards to lipid ex-
periments, the U937 cell study could be revisited, using ox-LDL rather than native-LDL (which
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was used throughout the LDL experiments). This may increase the uptake and signal of the
contrast agents gold and iodine. Another modification for the U937 study would be looking
into increasing the number of iodine or gold atoms per LDL, hence a higher expectation of de-
tecting a signal from the contrast agents if the rate of uptake remained the same. Ferric nitrate
studies encompassed a large portion of this thesis. Future work includes creating an optimised
protocol that is capable of scanning plaques for calcifications and intraplaque haemorrhages.
This was attempted by using two scanning protocols to compare results, however issues running
the MD meant only one protocol could be used for analysis. For the FeCl/CaCl experiment,
different concentrations within the mixture solution could be trialled, to determine what con-
centrations of iron and calcium create the turning point at which iron is distinguished over
calcium. Principal component analysis (PCA) was applied to ferric nitrate datasets to observe
its ability to distinguish materials. Improvements to the PCA code to incorporate more than
one material into the ROI selection could improve the ability of PCA to distinguish materials.
There was success in scanning plaque specimens, apoE mice and excised mice aorta and liver.
Next steps include lipid staining of plaques and histology to confirm the presence of lipid with
the images from MARS Vision. Future work could also involve scanning plaque specimens and
apoE mice with the ferric nitrate phantom and protocol once this has been optimised, in the
hope of observing intraplaque haemorrhage alongside calcifications. Work involving intravenous
injection of gold nanoparticles into apoE mice to observe areas of contrast agent uptake would
be a worthwhile ongoing experiment for atherosclerosis research using spectral CT.
This thesis details work contributing to the quantification of vulnerable atherosclerotic
plaque features using MARS spectral CT. Multi-energy CT is a superior imaging modality
for atherosclerosis research compared to current imaging modalities, enabling users to acquire
multi-energy datasets from a single acquisition using a standard x-ray tube operated at a single
accelerating voltage. This gives spectral CT the advantage over current imaging techniques,
which do not possess the spatial resolution to distinguish material components by morphology
nor the spectroscopic ability to determine the composition from characteristic spectral informa-
tion. Until a suitable technique becomes clinically available, the field of medical imaging will
be restricted in its ability to identify vulnerable atherosclerotic plaque in patients. This thesis
demonstrates the potential of spectral CT to identify material components of atherosclerotic
plaque in vivo, which relates to the long term goals of the MARS group, as they translate this
technology to a commercial, human scale MARS scanner. With application in atherosclerosis
many other diseases, the MARS spectral scanner is a true asset in the field of medical imaging.
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